Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coregulator activity	ZNF410 SUPT20HL1 BCL9L PARK7 MAML1 SUPT20HL2 MED13L BCL9 ARID1A MIDEAS CREBBP NCOA5 KMT2D MTA1 MTA3 ATF7IP SS18L1 SMARCC2 MAML3 EP300 VGLL1	3.56e-08	562	179	21	GO:0003712
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	ZNF410 MAPK8IP1 SUPT20HL1 BCL9L UBQLN2 GAS2L3 PARK7 MAML1 SUPT20HL2 SH2D2A MED13L BCL9 ARID1A WNK1 MIDEAS CREBBP SH2B1 NCOA5 YTHDF1 KSR1 KMT2D MTA1 MTA3 ATF7IP SS18L1 TNRC6A SMARCC2 MAML3 EP300 VGLL1 TNS3	4.23e-08	1160	179	31	GO:0030674
GeneOntologyMolecularFunction	molecular adaptor activity	ZNF410 MAPK8IP1 SUPT20HL1 BCL9L UBQLN2 GAS2L3 PARK7 MAML1 SUPT20HL2 SH2D2A MED13L BCL9 ARID1A WNK1 MIDEAS CREBBP SH2B1 NCOA5 YTHDF1 KSR1 KMT2D MTA1 MTA3 ATF7IP SS18L1 TNRC6A SMARCC2 DLG1 BAG6 MAML3 EP300 VGLL1 TNS3	1.32e-07	1356	179	33	GO:0060090
GeneOntologyMolecularFunction	transcription coactivator activity	BCL9L PARK7 MAML1 BCL9 ARID1A CREBBP KMT2D MTA1 MTA3 SS18L1 SMARCC2 MAML3 EP300 VGLL1	6.37e-07	303	179	14	GO:0003713
GeneOntologyMolecularFunction	structural constituent of nuclear pore	NUP58 POM121C POM121 NPAP1 POM121B	2.51e-06	25	179	5	GO:0017056
GeneOntologyMolecularFunction	cAMP response element binding protein binding	SIK1 CRTC1 CREBBP CREM	2.92e-06	12	179	4	GO:0008140
GeneOntologyMolecularFunction	nuclear localization sequence binding	NUP58 POM121C POM121 NPAP1 POM121B	3.77e-06	27	179	5	GO:0008139
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	SOX1 FOXO3 ZNF410 FOXO3B SP3 KLF12 HSFX4 ZEB1 ZNF628 ZBTB48 ZNF805 SIX4 ZNF236 CREBBP CREM ZNF835 MYEF2 PKNOX2 TFCP2L1 USF3 MTA1 HOXD3 NFIA MZF1 PURA HSFX3 ATF1 KDM6A TCFL5 EP300 MYBL2	5.82e-06	1459	179	31	GO:0000977
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SOX1 FOXO3 ZNF410 FOXO3B SP3 KLF12 HSFX4 ZEB1 ZNF628 ZBTB48 ZNF805 SIX4 ZNF236 CREM ZNF835 MYEF2 PKNOX2 TFCP2L1 MTA1 HOXD3 NFIA MZF1 HSFX3 ATF1 KDM6A TCFL5 EP300 MYBL2	6.07e-06	1244	179	28	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SOX1 FOXO3 ZNF410 FOXO3B SP3 KLF12 HSFX4 ZEB1 ZNF628 ZBTB48 ZNF805 SIX4 ZNF236 CREM ZNF835 MYEF2 PKNOX2 TFCP2L1 MTA1 HOXD3 NFIA MZF1 HSFX3 ATF1 KDM6A TCFL5 EP300 MYBL2	9.05e-06	1271	179	28	GO:0000987
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	SOX1 FOXO3 FOXO3B SP3 KLF12 ZEB1 ZNF628 ZBTB48 TSHZ2 ZNF805 SIX4 VSX1 ZNF236 CREM MYEF2 PKNOX2 TFCP2L1 KMT2D USF3 HOXD3 NFIA MZF1 PURA HSFX3 ATF1 TCFL5 HOMEZ MYBL2	6.00e-05	1412	179	28	GO:0000981
GeneOntologyMolecularFunction	peptide lactyltransferase (CoA-dependent) activity	CREBBP EP300	7.99e-05	2	179	2	GO:0120300
GeneOntologyMolecularFunction	histone H3K27 acetyltransferase activity	CREBBP EP300	7.99e-05	2	179	2	GO:0044017
GeneOntologyMolecularFunction	signal sequence binding	NUP58 POM121C POM121 NPAP1 POM121B	9.21e-05	51	179	5	GO:0005048
GeneOntologyMolecularFunction	structural constituent of postsynaptic actin cytoskeleton	POTEF POTEE POTEI	1.11e-04	11	179	3	GO:0098973
GeneOntologyMolecularFunction	structural constituent of postsynapse	POTEF POTEE DLG1 POTEI	1.85e-04	32	179	4	GO:0099186
GeneOntologyMolecularFunction	histone H3K18 acetyltransferase activity	CREBBP EP300	2.38e-04	3	179	2	GO:0043993
GeneOntologyMolecularFunction	structural constituent of synapse	POTEF POTEE DLG1 POTEI	5.36e-04	42	179	4	GO:0098918
GeneOntologyMolecularFunction	G protein-coupled adenosine receptor activity	ADORA2A ADORA2B	1.63e-03	7	179	2	GO:0001609
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	SOX1 FOXO3 ZNF410 SUPT20HL1 BCL9L SP3 KLF12 ZEB1 MYO1C PARK7 MAML1 CRTC1 SUPT20HL2 SIX4 BCL9 CREBBP CREM TFCP2L1 KMT2D USF3 HOXD3 NFIA MZF1 SS18L1 MED25 ATF1 KDM6A MAML3 EP300 MYBL2	3.27e-06	1390	179	30	GO:0045944
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	SOX1 FOXO3 SP3 KLF12 ZEB1 TRO SIK1 ARID1A CREBBP CREM MYEF2 NCOA5 ZNF469 TFCP2L1 MTA1 PER3 MTA3 MZF1 ATF7IP PURA MED25 SMARCC2 DLG1 TCFL5 EP300	4.70e-06	1053	179	25	GO:0000122
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	SOX1 FOXO3 SP3 KLF12 ZEB1 TRO SIK1 SIX4 ARID1A MIDEAS CREBBP CREM MYEF2 PHC1 NCOA5 ZNF469 TFCP2L1 MTA1 PER3 MTA3 MZF1 ATF7IP PURA MED25 SMARCC2 DLG1 TASOR TCFL5 EP300	1.28e-05	1413	179	29	GO:1902679
GeneOntologyBiologicalProcess	nuclear pore organization	SEH1L POM121C POM121 POM121B	1.53e-05	18	179	4	GO:0006999
GeneOntologyBiologicalProcess	gastrulation	SUPT20HL1 FN1 SUPT20HL2 TNRC6C ARID1A WNK1 MEGF8 MACF1 TASOR KDM6A	1.70e-05	212	179	10	GO:0007369
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	SOX1 FOXO3 SP3 KLF12 ZEB1 TRO SIK1 SIX4 ARID1A MIDEAS CREBBP CREM MYEF2 PHC1 NCOA5 ZNF469 TFCP2L1 MTA1 PER3 MTA3 MZF1 ATF7IP PURA MED25 SMARCC2 DLG1 TCFL5 EP300	2.89e-05	1399	179	28	GO:0045892
GeneOntologyBiologicalProcess	embryonic morphogenesis	SUPT20HL1 SP3 SHROOM3 ZEB1 FN1 SUPT20HL2 TNRC6C SIX4 ARID1A WNK1 CREBBP BPNT2 HOXD3 MEGF8 DLG1 MACF1 TASOR KDM6A	5.10e-05	713	179	18	GO:0048598
GeneOntologyBiologicalProcess	regulation of potassium ion import	WNK1 DLG1 WNK2	5.20e-05	9	179	3	GO:1903286
GeneOntologyBiologicalProcess	entrainment of circadian clock by photoperiod	SIK1 CRTC1 MTA1 PER3	6.02e-05	25	179	4	GO:0043153
GeneOntologyBiologicalProcess	protein localization to nucleus	PARK7 NUP58 SIX4 POM121C CREBBP ABCA7 POM121 EIF4ENIF1 NPAP1 POM121B EP300 AGAP3	8.01e-05	362	179	12	GO:0034504
GeneOntologyBiologicalProcess	photoperiodism	SIK1 CRTC1 MTA1 PER3	9.54e-05	28	179	4	GO:0009648
GeneOntologyBiologicalProcess	entrainment of circadian clock	SIK1 CRTC1 MTA1 PER3	1.26e-04	30	179	4	GO:0009649
GeneOntologyCellularComponent	chromatin	SOX1 FOXO3 SUPT20HL1 SP3 KLF12 ZEB1 MYO1C TSHZ2 POTEF PARK7 SUPT20HL2 SIX4 VSX1 ARID1A CREBBP CREM PHC1 POTEE TFCP2L1 MTA1 MTA3 HOXD3 NFIA SS18L1 HSFX3 TMPO SMARCC2 BICRAL ATF1 POTEI TASOR TCFL5 EP300 SLX4 HOMEZ	3.88e-08	1480	180	35	GO:0000785
GeneOntologyCellularComponent	nuclear protein-containing complex	FOXO3 SEH1L BCL9L MYO1C NUP58 MED13L BCL9 ARID1A POM121C MIDEAS CREBBP CREM PHC1 WDR74 KMT2D MTA1 POM121 MTA3 SS18L1 NPAP1 MED25 SNRNP40 SMARCC2 BICRAL ATF1 POM121B KDM6A SLX4 CSTF2T MYBL2	2.33e-06	1377	180	30	GO:0140513
GeneOntologyCellularComponent	histone acetyltransferase complex	SUPT20HL1 POTEF SUPT20HL2 CREBBP POTEE POTEI EP300	1.70e-05	94	180	7	GO:0000123
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	MYO1C ARID1A MTA1 MTA3 SS18L1 SMARCC2 BICRAL	1.95e-05	96	180	7	GO:0070603
GeneOntologyCellularComponent	protein acetyltransferase complex	SUPT20HL1 POTEF SUPT20HL2 CREBBP POTEE POTEI EP300	3.29e-05	104	180	7	GO:0031248
GeneOntologyCellularComponent	acetyltransferase complex	SUPT20HL1 POTEF SUPT20HL2 CREBBP POTEE POTEI EP300	4.44e-05	109	180	7	GO:1902493
GeneOntologyCellularComponent	ATPase complex	MYO1C ARID1A MTA1 MTA3 SS18L1 SMARCC2 BICRAL	1.29e-04	129	180	7	GO:1904949
GeneOntologyCellularComponent	transcription regulator complex	FOXO3 BCL9L SP3 SIX4 BCL9 MIDEAS CREBBP CREM TFCP2L1 MTA1 MTA3 ATF7IP MED25 ATF1 EP300	2.10e-04	596	180	15	GO:0005667
GeneOntologyCellularComponent	nuclear pore	SEH1L NUP58 POM121C POM121 NPAP1 POM121B	2.42e-04	101	180	6	GO:0005643
GeneOntologyCellularComponent	actin filament	PRICKLE4 MYO1C GAS2L3 POTEF POTEE POTEI DMTN	2.77e-04	146	180	7	GO:0005884
GeneOntologyCellularComponent	nBAF complex	ARID1A SS18L1 SMARCC2	3.24e-04	16	180	3	GO:0071565
GeneOntologyCellularComponent	cell projection membrane	PLB1 CYBRD1 MYO1C PIEZO1 ABCA7 ADORA2A KSR1 CSPG4 NPC1L1 DLG1 MACF1 DMTN	3.73e-04	431	180	12	GO:0031253
GeneOntologyCellularComponent	ATF4-CREB1 transcription factor complex	CREM ATF1	4.37e-04	4	180	2	GO:1990589
GeneOntologyCellularComponent	PML body	SP3 PARK7 CREBBP EIF4ENIF1 SIMC1 AGAP3	7.54e-04	125	180	6	GO:0016605
GeneOntologyCellularComponent	actin cytoskeleton	DENND2A PRICKLE4 SHROOM3 MYO1C GAS2L3 POTEF NCOA5 PKNOX2 POTEE MACF1 POTEI DMTN TNS3	1.50e-03	576	180	13	GO:0015629
GeneOntologyCellularComponent	P-body	EDC3 TNRC6C YTHDF1 EIF4ENIF1 TNRC6A	1.90e-03	102	180	5	GO:0000932
GeneOntologyCellularComponent	nuclear body	SP3 MYO1C PARK7 MAML1 CRTC1 CREBBP REXO1 PHC1 BPNT2 EIF4ENIF1 HOXD3 ATF7IP SS18L1 SIMC1 SNRNP40 MAML3 AGAP3	2.11e-03	903	180	17	GO:0016604
GeneOntologyCellularComponent	SWI/SNF complex	ARID1A SMARCC2 BICRAL	2.15e-03	30	180	3	GO:0016514
GeneOntologyCellularComponent	leading edge membrane	MYO1C PIEZO1 ABCA7 ADORA2A KSR1 CSPG4 MACF1	2.33e-03	210	180	7	GO:0031256
GeneOntologyCellularComponent	NuA4 histone acetyltransferase complex	POTEF POTEE POTEI	2.59e-03	32	180	3	GO:0035267
GeneOntologyCellularComponent	H4/H2A histone acetyltransferase complex	POTEF POTEE POTEI	2.59e-03	32	180	3	GO:0043189
HumanPheno	Hernia	FAT4 ZEB1 SIK1 MED13L ARID1A CREBBP SH2B1 PHGDH SLC25A22 PACS1 ZNF469 KMT2D MEGF8 NFIA GUSB MED25 SMARCC2 MN1 KDM6A TNXB SLX4	5.63e-07	589	57	21	HP:0100790
HumanPheno	Pilomatrixoma	CREBBP KMT2D KDM6A EP300	1.70e-06	9	57	4	HP:0030434
HumanPheno	Abnormality of the abdominal wall	FAT4 ZEB1 PIEZO1 SIK1 MED13L ARID1A CREBBP PHGDH SLC25A22 PACS1 KMT2D ALKBH8 MEGF8 NFIA GUSB MED25 SMARCC2 KDM6A SLX4	5.11e-06	560	57	19	HP:0004298
HumanPheno	Chiari type I malformation	CREBBP SH2B1 KMT2D NFIA KDM6A EP300	1.28e-05	48	57	6	HP:0007099
HumanPheno	Hernia of the abdominal wall	FAT4 ZEB1 SIK1 MED13L ARID1A CREBBP PHGDH SLC25A22 PACS1 KMT2D MEGF8 NFIA GUSB MED25 SMARCC2 KDM6A SLX4	2.18e-05	506	57	17	HP:0004299
HumanPheno	Short phalanx of finger	FN1 COMP SIK1 FBXO11 ARID1A CREBBP SLC25A22 PACS1 KMT2D MEGF8 MED25 KDM6A EP300	2.28e-05	306	57	13	HP:0009803
HumanPheno	Abdominal wall defect	FAT4 ZEB1 SIK1 MED13L ARID1A CREBBP PHGDH SLC25A22 PACS1 KMT2D MEGF8 NFIA GUSB MED25 SMARCC2 KDM6A SLX4	2.48e-05	511	57	17	HP:0010866
HumanPheno	Thoracoabdominal wall defect	FAT4 ZEB1 SIK1 MED13L ARID1A CREBBP PHGDH SLC25A22 PACS1 KMT2D MEGF8 NFIA GUSB MED25 SMARCC2 KDM6A SLX4	2.48e-05	511	57	17	HP:0100656
HumanPheno	Syringomyelia	FBXO11 CREBBP SH2B1 NFIA EP300	2.74e-05	33	57	5	HP:0003396
HumanPheno	Frontal upsweep of hair	FBXO11 MED13L CREBBP NPAP1 EP300	2.74e-05	33	57	5	HP:0002236
HumanPheno	Premature thelarche	CREBBP KMT2D KDM6A EP300	3.01e-05	17	57	4	HP:0010314
HumanPheno	Prominent eyelashes	ARID1A KMT2D SMARCC2 KDM6A	3.01e-05	17	57	4	HP:0011231
HumanPheno	Aplasia/Hypoplasia of the phalanges of the hand	FN1 COMP SIK1 FBXO11 ARID1A CREBBP SLC25A22 PACS1 KMT2D MEGF8 MED25 KDM6A EP300	3.54e-05	319	57	13	HP:0009767
HumanPheno	Skin appendage neoplasm	CREBBP KMT2D KDM6A EP300	3.84e-05	18	57	4	HP:0012842
HumanPheno	Nasolacrimal duct obstruction	CREBBP KMT2D MEGF8 KDM6A EP300	4.25e-05	36	57	5	HP:0000579
HumanPheno	Congenital abnormal hair pattern	FAT4 FBXO11 MED13L ARID1A CREBBP SH2B1 PACS1 KMT2D MEGF8 NPAP1 SMARCC2 KDM6A EP300	4.60e-05	327	57	13	HP:0011361
HumanPheno	Brachydactyly (hand)	FN1 COMP SIK1 FBXO11 ARID1A CREBBP SLC25A22 PACS1 KMT2D MEGF8 MED25 SMARCC2 KDM6A EP300 SLX4	4.94e-05	430	57	15	HP:0100667
HumanPheno	Abnormal thorax morphology	COL4A6 FAT4 ZEB1 FN1 COMP PIEZO1 SIK1 FBXO11 TNFRSF11A MED13L ARID1A CREBBP SH2B1 PHGDH SLC25A22 PACS1 KY KMT2D USF3 MEGF8 NFIA GUSB MED25 SMARCC2 HERC1 MN1 KDM6A EP300 SLX4	4.96e-05	1328	57	29	HP:0000765
HumanPheno	Abnormal upper limb bone morphology	FAT4 FN1 COMP SIK1 FBXO11 TNFRSF11A WNK1 CREBBP SLC25A22 PACS1 BPNT2 MEGF8 GUSB MED25 EP300 SLX4	5.01e-05	484	57	16	HP:0040070
HumanPheno	Recurrent respiratory infections	COL4A6 FAT4 SIK1 FBXO11 TNFRSF11A ARID1A CREBBP SLC25A22 KMT2D COG6 GUSB PURA NPAP1 MED25 SMARCC2 UMPS KDM6A HYDIN EP300	5.52e-05	660	57	19	HP:0002205
HumanPheno	Abnormal cardiac septum morphology	PIEZO1 SIK1 FBXO11 TNFRSF11A MED13L ARID1A CREBBP SH2B1 PHGDH SLC25A22 PACS1 KMT2D ALKBH8 MEGF8 COG6 MED25 SMARCC2 MACF1 KDM6A EP300 SLX4	5.95e-05	787	57	21	HP:0001671
HumanPheno	Abnormality of cranial sutures	FAT4 FBXO11 REN WNK1 CREBBP SH2B1 BPNT2 KMT2D MEGF8 NFIA PURA HERC1 KDM6A EP300	6.48e-05	388	57	14	HP:0011329
HumanPheno	Long eyelashes	FBXO11 ARID1A CREBBP PACS1 KMT2D SMARCC2 KDM6A EP300	7.92e-05	129	57	8	HP:0000527
HumanPheno	Abnormal hair whorl	FBXO11 MED13L CREBBP NPAP1 EP300	9.10e-05	42	57	5	HP:0010721
HumanPheno	Ventricular septal defect	SIK1 TNFRSF11A MED13L ARID1A CREBBP PHGDH SLC25A22 PACS1 KMT2D ALKBH8 COG6 MED25 SMARCC2 MACF1 KDM6A EP300	9.46e-05	510	57	16	HP:0001629
HumanPheno	Cervical cord compression	COMP CREBBP EP300	1.06e-04	9	57	3	HP:0002341
HumanPheno	Abnormality of the tubular bones	FAT4 FN1 COMP SIK1 FBXO11 TNFRSF11A CREBBP SLC25A22 PACS1 BPNT2 ZNF469 MEGF8 GUSB NPAP1 MED25 HERC1 EP300 SLX4	1.08e-04	632	57	18	HP:0100713
HumanPheno	Abnormality of the long tubular bones	FAT4 FN1 COMP SIK1 FBXO11 TNFRSF11A CREBBP SLC25A22 PACS1 BPNT2 ZNF469 MEGF8 GUSB NPAP1 MED25 HERC1 EP300 SLX4	1.08e-04	632	57	18	HP:0100714
HumanPheno	Abnormal ventricular septum morphology	SIK1 TNFRSF11A MED13L ARID1A CREBBP PHGDH SLC25A22 PACS1 KMT2D ALKBH8 COG6 MED25 SMARCC2 MACF1 KDM6A EP300	1.22e-04	521	57	16	HP:0010438
HumanPheno	Plantar crease between first and second toes	CREBBP EP300	1.23e-04	2	57	2	HP:0008107
HumanPheno	Aortic isthmus hypoplasia	CREBBP EP300	1.23e-04	2	57	2	HP:0034227
HumanPheno	High axial triradius	CREBBP EP300	1.23e-04	2	57	2	HP:0001042
HumanPheno	Inguinal hernia	FAT4 ZEB1 ARID1A CREBBP PHGDH PACS1 KMT2D NFIA GUSB MED25 SMARCC2 KDM6A	1.31e-04	312	57	12	HP:0000023
HumanPheno	Spinal cord lesion	FBXO11 CREBBP SH2B1 NFIA EP300	1.42e-04	46	57	5	HP:0100561
HumanPheno	Flat face	FAT4 FN1 CREBBP BPNT2 GUSB MN1 EP300	1.56e-04	106	57	7	HP:0012368
HumanPheno	Broad phalanx of the toes	SIK1 CREBBP SLC25A22 MED25 EP300	1.57e-04	47	57	5	HP:0010174
HumanPheno	Aplasia/hypoplasia involving bones of the hand	FAT4 FN1 COMP SIK1 FBXO11 ARID1A CREBBP SLC25A22 BPNT2 KMT2D MEGF8 NPAP1 SMARCC2 KDM6A EP300 SLX4	1.79e-04	538	57	16	HP:0005927
HumanPheno	Atrial septal defect	PIEZO1 FBXO11 MED13L ARID1A CREBBP SH2B1 PHGDH PACS1 KMT2D MEGF8 COG6 MED25 SMARCC2 KDM6A EP300 SLX4	1.91e-04	541	57	16	HP:0001631
HumanPheno	Abnormality of the atrial septum	PIEZO1 FBXO11 MED13L ARID1A CREBBP SH2B1 PHGDH PACS1 KMT2D MEGF8 COG6 MED25 SMARCC2 KDM6A EP300 SLX4	1.91e-04	541	57	16	HP:0001630
HumanPheno	Low anterior hairline	MED13L ARID1A CREBBP SH2B1 PACS1 MEGF8 SMARCC2 EP300	1.98e-04	147	57	8	HP:0000294
HumanPheno	Abnormal atrial septum morphology	PIEZO1 FBXO11 MED13L ARID1A CREBBP SH2B1 PHGDH PACS1 KMT2D MEGF8 COG6 MED25 SMARCC2 KDM6A EP300 SLX4	2.04e-04	544	57	16	HP:0011994
HumanPheno	Broad phalanx	SIK1 FBXO11 CREBBP SLC25A22 PACS1 MEGF8 MED25 EP300	2.08e-04	148	57	8	HP:0006009
HumanPheno	Broad phalanges of the hand	SIK1 FBXO11 CREBBP SLC25A22 PACS1 MEGF8 MED25 EP300	2.08e-04	148	57	8	HP:0009768
HumanPheno	Abnormal lacrimal duct morphology	CREBBP KMT2D MEGF8 KDM6A EP300	2.12e-04	50	57	5	HP:0011481
HumanPheno	Abnormal morphology of bones of the upper limbs	FAT4 COMP SIK1 FBXO11 TNFRSF11A CREBBP SLC25A22 PACS1 BPNT2 MEGF8 GUSB MED25 EP300 SLX4	2.28e-04	436	57	14	HP:0040065
HumanPheno	Flared metaphysis	COMP SIK1 FBXO11 CREBBP SLC25A22 PACS1 MEGF8 MED25 EP300	2.29e-04	191	57	9	HP:0003015
HumanPheno	Sparse eyebrow	FBXO11 KMT2D MEGF8 COG6 PURA MED25 HERC1 KDM6A	2.39e-04	151	57	8	HP:0045075
HumanPheno	Abnormal cardiac atrium morphology	PIEZO1 FBXO11 MED13L ARID1A CREBBP SH2B1 PHGDH PACS1 KMT2D MEGF8 COG6 MED25 SMARCC2 KDM6A HYDIN EP300 SLX4	2.70e-04	617	57	17	HP:0005120
HumanPheno	Short columella	CREBBP KMT2D KDM6A EP300	2.72e-04	29	57	4	HP:0002000
HumanPheno	Broad eyebrow	FBXO11 CREBBP HERC1 EP300	2.72e-04	29	57	4	HP:0011229
HumanPheno	Broad finger	SIK1 FBXO11 CREBBP SLC25A22 PACS1 MEGF8 MED25 EP300	2.73e-04	154	57	8	HP:0001500
HumanPheno	Thin upper lip vermilion	FBXO11 ARID1A CREBBP PHC1 PACS1 KMT2D NFIA PURA NPAP1 SMARCC2 KDM6A EP300	2.87e-04	339	57	12	HP:0000219
HumanPheno	Thin lips	FBXO11 ARID1A CREBBP PHC1 PACS1 KMT2D NFIA PURA NPAP1 SMARCC2 KDM6A EP300	2.87e-04	339	57	12	HP:0000213
HumanPheno	Aplasia/hypoplasia of the extremities	FAT4 FN1 COMP SIK1 FBXO11 HMGCR TNFRSF11A ARID1A CREBBP PHGDH SLC25A22 KY BPNT2 KMT2D MEGF8 NPAP1 SMARCC2 KDM6A EP300 SLX4	3.04e-04	813	57	20	HP:0009815
HumanPheno	Unusual infection	COL4A6 FAT4 SIK1 FBXO11 TNFRSF11A MED13L ARID1A CREBBP SLC25A22 ADORA2A KMT2D COG6 GUSB PURA NPAP1 MED25 SMARCC2 DLG1 UMPS KDM6A TNXB HYDIN EP300 SLX4	3.11e-04	1088	57	24	HP:0032101
HumanPheno	Avascular necrosis of the capital femoral epiphysis	FN1 COMP CREBBP EP300	3.11e-04	30	57	4	HP:0005743
HumanPheno	Broad long bones	SIK1 FBXO11 CREBBP SLC25A22 PACS1 MEGF8 MED25 EP300	3.12e-04	157	57	8	HP:0005622
HumanPheno	Abnormality of the hairline	FAT4 MED13L ARID1A CREBBP SH2B1 PACS1 KMT2D MEGF8 SMARCC2 KDM6A EP300	3.33e-04	294	57	11	HP:0009553
HumanPheno	Hip dysplasia	COMP CREBBP BPNT2 ZNF469 KMT2D COG6 NPAP1 UMPS KDM6A EP300	3.44e-04	247	57	10	HP:0001385
HumanPheno	Aplasia/hypoplasia involving bones of the upper limbs	FAT4 FN1 COMP SIK1 FBXO11 ARID1A CREBBP SLC25A22 BPNT2 KMT2D MEGF8 NPAP1 SMARCC2 KDM6A EP300 SLX4	3.64e-04	572	57	16	HP:0006496
HumanPheno	Laryngeal cartilage malformation	CREBBP EP300	3.66e-04	3	57	2	HP:0008752
HumanPheno	Phobia	CREBBP EP300	3.66e-04	3	57	2	HP:5200232
HumanPheno	Abnormal alveolar type II pneumocyte morphology	KMT2D KDM6A	3.66e-04	3	57	2	HP:0033245
HumanPheno	Agoraphobia	CREBBP EP300	3.66e-04	3	57	2	HP:0000756
HumanPheno	Decreased proportion of CD4-positive, alpha-beta memory T cells	KMT2D KDM6A	3.66e-04	3	57	2	HP:0410386
HumanPheno	Focal seizure with eyelid myoclonia	SIK1 SLC25A22	3.66e-04	3	57	2	HP:0011168
HumanPheno	Humoral immunodeficiency	CREBBP EP300	3.66e-04	3	57	2	HP:0005363
HumanPheno	Prominent nasal septum	CREBBP EP300	3.66e-04	3	57	2	HP:0005322
HumanPheno	Type II pneumocyte hyperplasia	KMT2D KDM6A	3.66e-04	3	57	2	HP:0033328
HumanPheno	Radial deviation of thumb terminal phalanx	CREBBP EP300	3.66e-04	3	57	2	HP:0005895
HumanPheno	Aplasia involving bones of the extremities	FAT4 FN1 COMP SIK1 FBXO11 HMGCR TNFRSF11A ARID1A CREBBP SLC25A22 KY BPNT2 KMT2D MEGF8 NPAP1 SMARCC2 KDM6A EP300 SLX4	3.67e-04	759	57	19	HP:0009825
HumanPheno	Recurrent infections	COL4A6 FAT4 SIK1 FBXO11 TNFRSF11A MED13L ARID1A CREBBP SLC25A22 KMT2D COG6 GUSB PURA NPAP1 MED25 SMARCC2 DLG1 UMPS KDM6A TNXB HYDIN EP300 SLX4	3.74e-04	1030	57	23	HP:0002719
HumanPheno	Clinodactyly	FAT4 FN1 FBXO11 MED13L ARID1A CREBBP PHGDH PACS1 KMT2D MEGF8 NPAP1 MED25 SMARCC2 KDM6A EP300 SLX4	3.79e-04	574	57	16	HP:0030084
HumanPheno	Aplasia/hypoplasia involving bones of the extremities	FAT4 FN1 COMP SIK1 FBXO11 HMGCR TNFRSF11A ARID1A CREBBP SLC25A22 KY BPNT2 KMT2D MEGF8 NPAP1 SMARCC2 KDM6A EP300 SLX4	3.80e-04	761	57	19	HP:0045060
HumanPheno	Abnormality of upper lip vermillion	FAT4 FBXO11 ARID1A CREBBP PHC1 PACS1 KMT2D NFIA PURA NPAP1 MED25 SMARCC2 KDM6A EP300	4.35e-04	464	57	14	HP:0011339
HumanPheno	Abnormality of refraction	COL4A6 ZEB1 FN1 FBXO11 VSX1 MED13L ARID1A CREBBP PACS1 ZNF469 USF3 PURA NPAP1 MED25 SMARCC2 HERC1 EP300 SLX4	4.69e-04	709	57	18	HP:0000539
HumanPheno	Renal hypoplasia/aplasia	FAT4 REN SH2B1 PHGDH PHC1 KMT2D ALKBH8 NFIA COG6 KDM6A TNXB SLX4	4.86e-04	359	57	12	HP:0008678
HumanPheno	Abnormal cranial suture/fontanelle morphology	FAT4 FBXO11 REN WNK1 CREBBP SH2B1 BPNT2 KMT2D MEGF8 NFIA PURA HERC1 KDM6A EP300	5.19e-04	472	57	14	HP:0000235
HumanPheno	Abnormal hip bone morphology	FAT4 FN1 COMP WNK1 CREBBP BPNT2 ZNF469 KMT2D MEGF8 COG6 GUSB NPAP1 MACF1 UMPS KDM6A EP300 SLX4	5.32e-04	653	57	17	HP:0003272
HumanPheno	Pneumonia	COL4A6 TNFRSF11A ARID1A CREBBP KMT2D PURA MED25 SMARCC2 KDM6A HYDIN EP300	5.39e-04	311	57	11	HP:0002090
HumanPheno	Abnormal toe phalanx morphology	SIK1 WNK1 CREBBP SLC25A22 MED25 EP300 SLX4	5.48e-04	130	57	7	HP:0010161
HumanPheno	Reduced circulating growth hormone concentration	CREBBP KMT2D KDM6A	5.50e-04	15	57	3	HP:0034323
HumanPheno	Abnormality of the frontal hairline	FAT4 MED13L ARID1A CREBBP SH2B1 PACS1 MEGF8 SMARCC2 EP300	5.52e-04	215	57	9	HP:0000599
HumanPheno	Focal motor seizure	SIK1 PHGDH SLC25A22 PACS1 KMT2D PURA KDM6A	5.74e-04	131	57	7	HP:0011153
HumanPheno	Depressed nasal ridge	FBXO11 CREBBP PHGDH KMT2D MEGF8 MN1 KDM6A	5.74e-04	131	57	7	HP:0000457
HumanPheno	Aplasia/Hypoplasia of fingers	FN1 COMP SIK1 ARID1A CREBBP SLC25A22 KMT2D MEGF8 SMARCC2 KDM6A EP300 SLX4	5.79e-04	366	57	12	HP:0006265
HumanPheno	Aspiration pneumonia	COL4A6 ARID1A KMT2D PURA SMARCC2 KDM6A	6.05e-04	95	57	6	HP:0011951
HumanPheno	Abnormality of the distal phalanx of the thumb	CREBBP BPNT2 MEGF8 EP300	6.36e-04	36	57	4	HP:0009617
HumanPheno	Hydrocele testis	PIEZO1 CREBBP KMT2D EP300	6.36e-04	36	57	4	HP:0000034
HumanPheno	Sparse lateral eyebrow	KMT2D COG6 PURA KDM6A	6.36e-04	36	57	4	HP:0005338
HumanPheno	Sparse and thin eyebrow	KMT2D COG6 PURA KDM6A	6.36e-04	36	57	4	HP:0000535
HumanPheno	Abnormal pelvic girdle bone morphology	FAT4 FN1 COMP WNK1 CREBBP KY BPNT2 ZNF469 KMT2D MEGF8 COG6 GUSB NPAP1 MACF1 UMPS KDM6A EP300 SLX4	6.72e-04	730	57	18	HP:0002644
HumanPheno	Patent foramen ovale	MED13L CREBBP PHGDH PACS1 KMT2D KDM6A EP300	6.88e-04	135	57	7	HP:0001655
HumanPheno	Respiratory tract infection	COL4A6 FAT4 SIK1 FBXO11 TNFRSF11A ARID1A CREBBP SLC25A22 KMT2D COG6 GUSB PURA NPAP1 MED25 SMARCC2 UMPS KDM6A HYDIN EP300	6.89e-04	797	57	19	HP:0011947
HumanPheno	Ocular hypertension	ZEB1 FN1 VSX1 NFIA	7.07e-04	37	57	4	HP:0007906
HumanPheno	Abnormal facial shape	FAT4 FN1 PIEZO1 FBXO11 REN MED13L ARID1A CREBBP SH2B1 PHGDH PACS1 BPNT2 KMT2D ALKBH8 MEGF8 NFIA GUSB PURA SMARCC2 DLG1 MACF1 HERC1 MN1 EP300 SLX4	7.14e-04	1221	57	25	HP:0001999
HumanPheno	Abnormal external genitalia	FAT4 ZEB1 PIEZO1 SIK1 FBXO11 IDH3A MED13L USP9Y ARID1A CREBBP PHGDH SLC25A22 PACS1 KMT2D USF3 ALKBH8 MEGF8 NFIA GUSB NPAP1 MED25 SMARCC2 HERC1 KDM6A TNXB EP300 SLX4	7.16e-04	1372	57	27	HP:0000811
HumanPheno	Brachydactyly	FN1 COMP SIK1 FBXO11 ARID1A CREBBP SLC25A22 PACS1 BPNT2 KMT2D USF3 MEGF8 MED25 SMARCC2 KDM6A EP300 SLX4	7.19e-04	670	57	17	HP:0001156
HumanPheno	Trichiasis	CREBBP EP300	7.28e-04	4	57	2	HP:0001128
HumanPheno	Visceral hemangioma	CREBBP EP300	7.28e-04	4	57	2	HP:0410266
Domain	Myb_DNA-binding	MIDEAS MTA1 MTA3 SMARCC2 MYBL2	1.62e-05	35	172	5	PF00249
Domain	MYB_LIKE	MIDEAS MTA1 MTA3 SMARCC2 MYBL2	2.45e-05	38	172	5	PS50090
Domain	Homeodomain-like	ZEB1 TSHZ2 SIX4 VSX1 MIDEAS PKNOX2 MTA1 MTA3 HOXD3 SMARCC2 HOMEZ MYBL2	6.09e-05	332	172	12	IPR009057
Domain	Nuc_rcpt_coact_CREBbp	CREBBP EP300	8.43e-05	2	172	2	IPR014744
Domain	BCL9	BCL9L BCL9	8.43e-05	2	172	2	PF11502
Domain	ZnF_TAZ	CREBBP EP300	8.43e-05	2	172	2	SM00551
Domain	-	CREBBP EP300	8.43e-05	2	172	2	1.20.1020.10
Domain	RING_CBP-p300	CREBBP EP300	8.43e-05	2	172	2	IPR010303
Domain	-	CREBBP EP300	8.43e-05	2	172	2	1.10.1630.10
Domain	Creb_binding	CREBBP EP300	8.43e-05	2	172	2	PF09030
Domain	zf-TAZ	CREBBP EP300	8.43e-05	2	172	2	PF02135
Domain	ZF_TAZ	CREBBP EP300	8.43e-05	2	172	2	PS50134
Domain	KAT11	CREBBP EP300	8.43e-05	2	172	2	SM01250
Domain	Znf_TAZ	CREBBP EP300	8.43e-05	2	172	2	IPR000197
Domain	KIX	CREBBP EP300	8.43e-05	2	172	2	PF02172
Domain	Bcl-9	BCL9L BCL9	8.43e-05	2	172	2	IPR015668
Domain	BCL9_beta-catenin-bd_dom	BCL9L BCL9	8.43e-05	2	172	2	IPR024670
Domain	HAT_KAT11	CREBBP EP300	8.43e-05	2	172	2	PF08214
Domain	KIX	CREBBP EP300	8.43e-05	2	172	2	PS50952
Domain	M_domain	TNRC6C TNRC6A	8.43e-05	2	172	2	PF12938
Domain	CBP_P300_HAT	CREBBP EP300	8.43e-05	2	172	2	IPR031162
Domain	DUF902	CREBBP EP300	8.43e-05	2	172	2	PF06001
Domain	GW182_M_dom	TNRC6C TNRC6A	8.43e-05	2	172	2	IPR026805
Domain	-	CREBBP EP300	8.43e-05	2	172	2	1.10.246.20
Domain	Histone_AcTrfase_Rtt109/CBP	CREBBP EP300	8.43e-05	2	172	2	IPR013178
Domain	KIX_dom	CREBBP EP300	8.43e-05	2	172	2	IPR003101
Domain	CBP_P300_HAT	CREBBP EP300	8.43e-05	2	172	2	PS51727
Domain	SANT_dom	MIDEAS MTA1 MTA3 SMARCC2	8.86e-05	26	172	4	IPR017884
Domain	SANT	MIDEAS MTA1 MTA3 SMARCC2 MYBL2	9.47e-05	50	172	5	SM00717
Domain	SANT/Myb	MIDEAS MTA1 MTA3 SMARCC2 MYBL2	1.14e-04	52	172	5	IPR001005
Domain	SANT	MIDEAS MTA1 MTA3 SMARCC2	1.20e-04	28	172	4	PS51293
Domain	ELM2_dom	MIDEAS MTA1 MTA3	2.05e-04	13	172	3	IPR000949
Domain	ELM2	MIDEAS MTA1 MTA3	2.05e-04	13	172	3	PF01448
Domain	ELM2	MIDEAS MTA1 MTA3	2.05e-04	13	172	3	PS51156
Domain	ELM2	MIDEAS MTA1 MTA3	2.05e-04	13	172	3	SM01189
Domain	Ago_hook	TNRC6C TNRC6A	2.51e-04	3	172	2	PF10427
Domain	Lsm14_N	EDC3 LSM14B	2.51e-04	3	172	2	IPR025609
Domain	LSM14	EDC3 LSM14B	2.51e-04	3	172	2	SM01271
Domain	MamL-1	MAML1 MAML3	2.51e-04	3	172	2	SM01275
Domain	pKID	CREM ATF1	2.51e-04	3	172	2	PF02173
Domain	DFDF	EDC3 LSM14B	2.51e-04	3	172	2	IPR025762
Domain	Neuroggenic_mastermind-like_N	MAML1 MAML3	2.51e-04	3	172	2	IPR019082
Domain	LSM14	EDC3 LSM14B	2.51e-04	3	172	2	PF12701
Domain	KID	CREM ATF1	2.51e-04	3	172	2	PS50953
Domain	FDF	EDC3 LSM14B	2.51e-04	3	172	2	PF09532
Domain	FDF_dom	EDC3 LSM14B	2.51e-04	3	172	2	IPR019050
Domain	TNRC6_PABC-bd	TNRC6C TNRC6A	2.51e-04	3	172	2	IPR032226
Domain	Argonaute_hook_dom	TNRC6C TNRC6A	2.51e-04	3	172	2	IPR019486
Domain	MamL-1	MAML1 MAML3	2.51e-04	3	172	2	PF09596
Domain	FDF	EDC3 LSM14B	2.51e-04	3	172	2	SM01199
Domain	TNRC6-PABC_bdg	TNRC6C TNRC6A	2.51e-04	3	172	2	PF16608
Domain	DFDF	EDC3 LSM14B	2.51e-04	3	172	2	PS51512
Domain	Coactivator_CBP_pKID	CREM ATF1	2.51e-04	3	172	2	IPR003102
Domain	Actin_CS	POTEF POTEE POTEI	3.94e-04	16	172	3	IPR004001
Domain	ACTINS_2	POTEF POTEE POTEI	4.75e-04	17	172	3	PS00432
Domain	Fumarylacetoacetase_C-rel	FAHD2B FAHD2A	5.00e-04	4	172	2	IPR011234
Domain	Leuzip_CREB	CREM ATF1	5.00e-04	4	172	2	IPR001630
Domain	Adenosn_rcpt	ADORA2A ADORA2B	5.00e-04	4	172	2	IPR001634
Domain	FAA_hydrolase	FAHD2B FAHD2A	5.00e-04	4	172	2	PF01557
Domain	-	FAHD2B FAHD2A	5.00e-04	4	172	2	3.90.850.10
Domain	Actin/actin-like_CS	POTEF POTEE POTEI	5.66e-04	18	172	3	IPR020902
Domain	ACTINS_ACT_LIKE	POTEF POTEE POTEI	6.67e-04	19	172	3	PS01132
Domain	Sterol-sensing	HMGCR NPC1L1	8.28e-04	5	172	2	PF12349
Domain	Nuc_rcpt_coact	CREBBP EP300	1.23e-03	6	172	2	IPR009110
Domain	OSR1_C	WNK1 WNK2	1.23e-03	6	172	2	PF12202
Domain	GAR	GAS2L3 MACF1	1.23e-03	6	172	2	PS51460
Domain	GAS2	GAS2L3 MACF1	1.23e-03	6	172	2	PF02187
Domain	Kinase_OSR1/WNK_CCT	WNK1 WNK2	1.23e-03	6	172	2	IPR024678
Domain	-	GAS2L3 MACF1	1.23e-03	6	172	2	3.30.920.20
Domain	GAS_dom	GAS2L3 MACF1	1.23e-03	6	172	2	IPR003108
Domain	GAS2	GAS2L3 MACF1	1.23e-03	6	172	2	SM00243
Domain	UBA	UBQLN2 SIK1 TNRC6C	2.60e-03	30	172	3	SM00165
Domain	Actin	POTEF POTEE POTEI	2.85e-03	31	172	3	IPR004000
Domain	Actin	POTEF POTEE POTEI	2.85e-03	31	172	3	PF00022
Domain	ACTIN	POTEF POTEE POTEI	2.85e-03	31	172	3	SM00268
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS	SEH1L NUP58 POM121C POM121 TNRC6A POM121B	1.18e-06	41	120	6	MM15200
Pathway	REACTOME_SUMOYLATION	SEH1L SP3 PARK7 NUP58 POM121C PHC1 MTA1 POM121 POM121B EP300	1.75e-06	169	120	10	MM14919
Pathway	REACTOME_GENE_SILENCING_BY_RNA	SEH1L NUP58 POM121C POM121 TNRC6A POM121B	3.48e-06	49	120	6	MM14837
Pathway	REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING	MAML1 CREBBP MAML3 EP300	4.68e-06	14	120	4	M27808
Pathway	REACTOME_SUMOYLATION	SEH1L SP3 PARK7 NUP58 POM121C CREBBP PHC1 MTA1 POM121 EP300	4.79e-06	189	120	10	M27214
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS	MAML1 CREBBP MAML3 EP300	8.40e-06	16	120	4	M27121
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	SEH1L NUP58 POM121C PHC1 POM121 POM121B	9.46e-06	58	120	6	MM15149
Pathway	REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	MYO1C ARID1A KMT2D MTA1 MTA3 ATF7IP SS18L1 SMARCC2 TASOR KDM6A EP300	1.08e-05	254	120	11	M27131
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	FOXO3 ARID1A CREBBP KDM6A MAML3 EP300	1.84e-05	65	120	6	M39682
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	SEH1L NUP58 POM121C PHC1 POM121 POM121B	1.84e-05	65	120	6	MM15147
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	SEH1L NUP58 POM121C POM121 POM121B	2.13e-05	40	120	5	MM14945
Pathway	REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML1 CREBBP MAML3 EP300	2.18e-05	20	120	4	M27881
Pathway	REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS	SEH1L COL4A6 NUP58 POM121C CREBBP POM121 EP300	2.41e-05	101	120	7	M27253
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	SEH1L NUP58 POM121C POM121 POM121B	2.72e-05	42	120	5	MM15039
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	SEH1L NUP58 POM121C POM121 POM121B	3.06e-05	43	120	5	MM14609
Pathway	BIOCARTA_VDR_PATHWAY	ARID1A CREBBP SMARCC2 EP300	4.65e-05	24	120	4	M13404
Pathway	REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION	SEH1L POM121C POM121 POM121B	4.65e-05	24	120	4	MM15658
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	SEH1L NUP58 POM121C PHC1 POM121	4.74e-05	47	120	5	M27395
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	SEH1L NUP58 POM121C POM121 POM121B	4.74e-05	47	120	5	MM14939
Pathway	REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML1 CREBBP MAML3 EP300	5.50e-05	25	120	4	M27880
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	SEH1L NUP58 POM121C POM121 POM121B	6.41e-05	50	120	5	MM14610
Pathway	REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX	BCL9L BCL9 KMT2D EP300	6.46e-05	26	120	4	MM14793
Pathway	REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING	MAML1 MAML3 EP300	6.91e-05	10	120	3	MM15535
Pathway	REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION	FOXO3 CREBBP EP300	6.91e-05	10	120	3	M27945
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	SEH1L NUP58 POM121C POM121 POM121B	7.06e-05	51	120	5	MM15151
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	SEH1L NUP58 POM121C PHC1 POM121 POM121B	7.94e-05	84	120	6	MM14929
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	SEH1L NUP58 POM121C POM121 TMPO	8.51e-05	53	120	5	M27212
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	SEH1L NUP58 POM121C POM121 POM121B	1.02e-04	55	120	5	MM14917
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	PADI4 ARID1A CREBBP KMT2D MTA1 MTA3 ATF7IP SMARCC2 KDM6A EP300	1.09e-04	272	120	10	M29619
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	PADI4 ARID1A KMT2D MTA1 MTA3 ATF7IP SMARCC2 KDM6A	1.24e-04	175	120	8	MM14941
Pathway	REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML1 MAML3 EP300	1.25e-04	12	120	3	M27159
Pathway	REACTOME_SNRNP_ASSEMBLY	SEH1L NUP58 POM121C POM121 POM121B	1.31e-04	58	120	5	MM14736
Pathway	REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS	SEH1L NUP58 POM121C POM121 POM121B EP300	1.32e-04	92	120	6	MM14951
Pathway	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	SEH1L NUP58 POM121C POM121	1.49e-04	32	120	4	M29579
Pathway	REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS	SEH1L NUP58 POM121C POM121	1.69e-04	33	120	4	M27016
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	ARID1A PHC1 SMARCC2 EP300	1.90e-04	34	120	4	MM15531
Pathway	REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN	SEH1L NUP58 POM121C POM121	1.90e-04	34	120	4	M27041
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS	ARID1A MTA1 MTA3 ATF7IP SS18L1 SMARCC2 TASOR	2.09e-04	142	120	7	M48257
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	SEH1L NUP58 POM121C POM121	2.13e-04	35	120	4	M27320
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	SEH1L NUP58 POM121C POM121	2.38e-04	36	120	4	M26974
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	SEH1L NUP58 POM121C POM121	2.38e-04	36	120	4	M27245
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	ARID1A PHC1 SMARCC2 EP300	2.65e-04	37	120	4	M27797
Pathway	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	SEH1L NUP58 POM121C POM121	2.65e-04	37	120	4	M1029
Pathway	REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS	SEH1L NUP58 POM121C POM121	2.65e-04	37	120	4	M27038
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES	FOXO3 CREBBP EP300	3.11e-04	16	120	3	M27940
Pathway	WP_CIRCADIAN_RHYTHM_GENES	SIK1 CRTC1 TNFRSF11A CREM ADORA2A MTA1 PER3 EP300	3.19e-04	201	120	8	M39605
Pathway	REACTOME_CIRCADIAN_CLOCK	SIK1 CRTC1 CREBBP CREM EP300	3.20e-04	70	120	5	M938
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	SEH1L NUP58 POM121C POM121	3.26e-04	39	120	4	M27238
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	SEH1L NUP58 POM121C PHC1 POM121	3.42e-04	71	120	5	M27394
Pathway	REACTOME_ADIPOGENESIS	MED13L CREBBP MTA1 MTA3 MED25 EP300	3.50e-04	110	120	6	M48259
Pathway	REACTOME_GENE_EXPRESSION_TRANSCRIPTION	FOXO3 SEH1L MYO1C MAML1 NUP58 ARID1A POM121C PHC1 KMT2D MTA1 POM121 MTA3 ATF7IP TNRC6A SMARCC2 POM121B KDM6A MAML3 EP300 CSTF2T	3.75e-04	1022	120	20	MM15436
Pathway	REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE	SEH1L NUP58 POM121C POM121 POM121B	3.89e-04	73	120	5	MM14948
Pathway	REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS	SEH1L NUP58 POM121C POM121	3.96e-04	41	120	4	M29574
Pathway	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	MAML1 CREBBP MAML3 EP300	4.35e-04	42	120	4	M17541
Pathway	REACTOME_SIGNALING_BY_NOTCH1	MAML1 MAML3 EP300	4.47e-04	18	120	3	MM14775
Pathway	REACTOME_ECM_PROTEOGLYCANS	COL4A6 FN1 COMP COL6A5 TNXB	4.69e-04	76	120	5	M27219
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	SEH1L NUP58 POM121C POM121	4.77e-04	43	120	4	M26975
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	SEH1L NUP58 POM121C PHC1 POM121	4.98e-04	77	120	5	M27226
Pathway	REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS	SEH1L NUP58 POM121C POM121	5.21e-04	44	120	4	M109
Pathway	REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS	PARK7 CREBBP PHC1 EP300	5.21e-04	44	120	4	M27295
Pathway	REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	MAML1 TNRC6C CREBBP TNRC6A MAML3 EP300	5.32e-04	119	120	6	M607
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	SEH1L NUP58 POM121C POM121	6.18e-04	46	120	4	M27397
Pathway	REACTOME_GLUCOSE_METABOLISM	SEH1L NUP58 POM121C POM121 POM121B	6.65e-04	82	120	5	MM15394
Pathway	REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE	SEH1L COL4A6 NUP58 POM121C POM121	6.65e-04	82	120	5	M27250
Pathway	REACTOME_ECM_PROTEOGLYCANS	FN1 COMP COL6A5 TNXB	6.71e-04	47	120	4	MM14925
Pathway	KEGG_NOTCH_SIGNALING_PATHWAY	MAML1 CREBBP MAML3 EP300	6.71e-04	47	120	4	M7946
Pathway	BIOCARTA_PELP1_PATHWAY	CREBBP EP300	7.07e-04	5	120	2	MM1575
Pathway	REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES	CREBBP EP300	7.07e-04	5	120	2	M48020
Pathway	REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES	CREBBP EP300	7.07e-04	5	120	2	M48023
Pathway	REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION	CREBBP EP300	7.07e-04	5	120	2	M27228
Pathway	WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX	FOXO3 CREBBP EP300	7.15e-04	21	120	3	M39593
Pathway	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML1 CREBBP MAML3 EP300	7.28e-04	48	120	4	M611
Pathway	REACTOME_SIGNALING_BY_NOTCH3	MAML1 CREBBP MAML3 EP300	7.87e-04	49	120	4	M618
Pathway	BIOCARTA_VDR_PATHWAY	ARID1A CREBBP EP300	8.23e-04	22	120	3	MM1370
Pathway	WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS	ZEB1 CREBBP PHGDH KSR1 EP300	8.26e-04	86	120	5	M39375
Pathway	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	SEH1L NUP58 POM121C POM121 POM121B	8.26e-04	86	120	5	MM15413
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1	TNRC6C ARID1A CREBBP PHC1 KMT2D TNRC6A SMARCC2 EP300	9.46e-04	237	120	8	M27786
Pathway	BIOCARTA_PELP1_PATHWAY	CREBBP EP300	1.05e-03	6	120	2	M22062
Pathway	REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION	FOXO3 EP300	1.05e-03	6	120	2	MM15660
Pathway	REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX	BCL9L BCL9 CREBBP KMT2D EP300	1.07e-03	91	120	5	M27101
Pathway	WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY	SP3 CREBBP PHC1 TFCP2L1 KMT2D MTA1 KDM6A EP300 MYBL2	1.08e-03	301	120	9	MM15983
Pathway	REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT	TNRC6C ARID1A CREBBP SS18L1 TNRC6A SMARCC2	1.11e-03	137	120	6	M48232
Pathway	REACTOME_SNRNP_ASSEMBLY	SEH1L NUP58 POM121C POM121	1.14e-03	54	120	4	M29594
Pathway	REACTOME_GENE_SILENCING_BY_RNA	SEH1L NUP58 TNRC6C POM121C POM121 TNRC6A	1.20e-03	139	120	6	M715
Pathway	REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION	TNRC6C ARID1A SS18L1 TNRC6A SMARCC2	1.29e-03	95	120	5	M48268
Pathway	PID_HDAC_CLASSIII_PATHWAY	FOXO3 CREBBP EP300	1.36e-03	26	120	3	M32
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3	FOXO3 MAML1 CREBBP MAML3 EP300	1.36e-03	96	120	5	M27784
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS	ARID1A MTA1 MTA3 SS18L1 SMARCC2	1.42e-03	97	120	5	M48262
Pathway	BIOCARTA_PPARG_PATHWAY	CREBBP EP300	1.47e-03	7	120	2	MM1573
Pathway	BIOCARTA_TERT_PATHWAY	SP3 MZF1	1.47e-03	7	120	2	MM1541
Pathway	REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS	TNRC6C TNRC6A	1.47e-03	7	120	2	M46421
Pathway	REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER	MAML1 CREBBP MAML3 EP300	1.49e-03	58	120	4	M29616
Pathway	REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION	SEH1L NUP58 POM121	1.52e-03	27	120	3	M29807
Pathway	REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS	SEH1L NUP58 POM121C POM121	1.58e-03	59	120	4	M27606
Pathway	REACTOME_TGFBR3_EXPRESSION	TNRC6C TNRC6A EP300	1.69e-03	28	120	3	M48253
Pathway	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY	MAML1 CREBBP MAML3	1.69e-03	28	120	3	M6177
Pathway	REACTOME_ATTENUATION_PHASE	COL4A6 CREBBP EP300	1.69e-03	28	120	3	M27254
Pathway	WP_KLEEFSTRA_SYNDROME	ARID1A SMARCC2 KDM6A	1.87e-03	29	120	3	M48076
Pathway	BIOCARTA_PPARG_PATHWAY	CREBBP EP300	1.95e-03	8	120	2	M22058
Pathway	REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES	CREBBP EP300	1.95e-03	8	120	2	M48022
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	BCL9L MAML1 NUP58 BCL9 ARID1A POM121C MIDEAS CREBBP PHGDH MYEF2 SLC30A6 NCOA5 YTHDF1 KMT2D POM121 EIF4ENIF1 FAM222B TNRC6A TMPO MAML3 EP300	5.35e-14	457	183	21	32344865
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FOXO3 SHROOM3 ZNF628 PIEZO1 MAML1 TNRC6C MED13L BCL9 ZNF236 ARID1A POM121C WNK1 REPIN1 ABCA7 REXO1 ADCY7 CCDC142 SLC25A22 KMT2D EIF4ENIF1 MEGF8 CSPG4 NAV2 PCNX1 HERC1 SIPA1L2 EP300 WNK2 MYBL2 AGAP3	1.71e-13	1105	183	30	35748872
Pubmed	Interaction network of human early embryonic transcription factors.	BCL9L ZEB1 MAML1 NUP58 SIX4 BCL9 ARID1A POM121C MIDEAS CREBBP KMT2D NFIA SS18L1 SMARCC2 KDM6A EP300 SLX4 HOMEZ	5.89e-13	351	183	18	38297188
Pubmed	Human transcription factor protein interaction networks.	BCL9L KLF12 ZEB1 EDC3 MYO1C MAML1 TNRC6C SIX4 VSX1 BCL9 ARID1A POM121C MIDEAS CREBBP YTHDF1 KMT2D MTA1 EIF4ENIF1 MTA3 NFIA ATF7IP PURA SS18L1 TNRC6A SMARCC2 ATF1 HERC1 LSM14B KDM6A EP300 SLX4 HOMEZ MYBL2	7.87e-13	1429	183	33	35140242
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SP3 KLF12 SHROOM3 UBQLN2 ZBTB48 TRO HJURP TSC22D2 BCL9 POM121C WNK1 SH2B1 PKNOX2 ZNF469 USF3 MTA1 POM121 EIF4ENIF1 WNK2	1.80e-12	430	183	19	35044719
Pubmed	A census of human transcription factors: function, expression and evolution.	SOX1 FOXO3 ZNF410 SP3 KLF12 ZEB1 ZBTB48 TSHZ2 TSC22D2 SIX4 VSX1 ZNF236 MIDEAS CREM PKNOX2 TFCP2L1 KMT2D USF3 HOXD3 NFIA MZF1 ATF1 TCFL5 HOMEZ MYBL2	1.61e-11	908	183	25	19274049
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	POM121C WNK1 REXO1 SH2B1 ARHGEF15 NCOA5 USF3 POM121 PER3 NFIA SS18L1 MACF1 POM121B TASOR MAML3 SLX4 CSTF2T	1.25e-09	493	183	17	15368895
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	MED13L ARID1A MIDEAS PHC1 TFCP2L1 KMT2D MTA1 MTA3 MED25 SMARCC2 MYBL2	1.57e-09	167	183	11	20362541
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	SEH1L MAML1 MED13L BCL9 ARID1A MIDEAS CREBBP PHGDH WDR74 KMT2D MTA1 MTA3 SNRNP40 TMPO SMARCC2 BICRAL ATF1 LSM14B KDM6A BAG6 EP300 CSTF2T HOMEZ MYBL2	4.58e-09	1103	183	24	34189442
Pubmed	A human MAP kinase interactome.	CRTC1 NUP58 POM121C WNK1 MIDEAS CREBBP USF3 POM121 ATF7IP SIMC1 TNRC6A NAV2 MACF1 BICRAL EP300 WNK2	7.52e-09	486	183	16	20936779
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	FAT4 GAS2L3 SLC25A34 MAML1 BCL9 ARID1A POM121C CREBBP MYEF2 KMT2D MEGF8 NFIA SS18L1 SMARCC2 KDM6A MAML3 EP300 MYBL2	9.20e-09	638	183	18	31182584
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	SIX4 BCL9 ARID1A MIDEAS KMT2D NFIA KDM6A EP300	1.42e-08	83	183	8	28794006
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	BCL9L MAML1 MED13L BCL9 ARID1A MIDEAS CREBBP KMT2D MTA3 NFIA SMARCC2 KDM6A	2.17e-08	268	183	12	33640491
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	BCL9L SP3 SHROOM3 EDC3 PIEZO1 MAML1 FBXO11 CRTC1 SIX4 REPIN1 PHGDH MYEF2 SLC30A6 POTEE MTA1 EIF4ENIF1 MTA3 PURA TNRC6A MED25 DLG1 MACF1 ATF1 LSM14B TASOR CSTF2T AGAP3	2.38e-08	1497	183	27	31527615
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	BCL9L SHROOM3 NUP58 BCL9 POM121C SLC30A6 NCOA5 NFIA TNRC6A TASOR	4.48e-08	180	183	10	35198878
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	BCL9L DENND2A ZEB1 MAML1 BCL9 ARID1A CREBBP EIF4ENIF1 ATF7IP SMARCC2 BAG6 EP300 CSTF2T MYBL2	6.70e-08	425	183	14	24999758
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MYO1C ARID1A POM121C REPIN1 CREBBP ABCA7 MYEF2 SLC25A22 KSR1 ZNF469 MTA1 EIF4ENIF1 MTA3 SS18L1 TNRC6A SMARCC2 MACF1 BICRAL CSMD1 SIPA1L2 EP300 AGAP3	1.18e-07	1116	183	22	31753913
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	MAML1 TNRC6C BCL9 MIDEAS CREBBP WDR74 FAM222B TNRC6A EP300	1.25e-07	152	183	9	38360978
Pubmed	Leveraging the Mendelian disorders of the epigenetic machinery to systematically map functional epigenetic variation.	CREBBP KMT2D KDM6A	1.43e-07	3	183	3	34463256
Pubmed	POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation.	POM121C POM121 POM121B	1.43e-07	3	183	3	30802453
Pubmed	Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex.	MAML1 CREBBP EP300	1.43e-07	3	183	3	12050117
Pubmed	Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine.	POM121C POM121 POM121B	1.43e-07	3	183	3	35507432
Pubmed	The KDM6A-KMT2D-p300 axis regulates susceptibility to diverse coronaviruses by mediating viral receptor expression.	KMT2D KDM6A EP300	1.43e-07	3	183	3	37410700
Pubmed	Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.	FOXO3 CREBBP EP300	1.43e-07	3	183	3	22474372
Pubmed	Dendrite development regulated by CREST, a calcium-regulated transcriptional activator.	CREBBP SS18L1 EP300	1.43e-07	3	183	3	14716005
Pubmed	CBP and p300 are essential for renin cell identity and morphological integrity of the kidney.	REN CREBBP EP300	1.43e-07	3	183	3	19252086
Pubmed	DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: potential involvement of direct inhibition of cAMP-responsive element (CRE)-binding protein/CRE modulator/activation transcription factor binding.	CREBBP CREM ATF1	1.43e-07	3	183	3	20413592
Pubmed	Histone acetyl transferases CBP and p300 are necessary for maintenance of renin cell identity and transformation of smooth muscle cells to the renin phenotype.	REN CREBBP EP300	1.43e-07	3	183	3	22523253
Pubmed	A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.	KMT2D KDM6A EP300	1.43e-07	3	183	3	28732206
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	ARID1A CREBBP PHC1 KMT2D MTA1 MTA3 SS18L1 SMARCC2 EP300	1.64e-07	157	183	9	30186101
Pubmed	Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.	SP3 ARID1A MIDEAS TFCP2L1 MTA3 NFIA SMARCC2	1.75e-07	77	183	7	19505873
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SP3 KLF12 SIX4 ARID1A CREBBP CREM PHC1 MEX3C PKNOX2 TFCP2L1 MTA1 MTA3 HOXD3 NFIA MACF1 MAML3 MYBL2	2.46e-07	709	183	17	22988430
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SOX1 FOXO3 ZNF410 SP3 KLF12 ZEB1 ZBTB48 SIX4 ZNF236 ARID1A CREM PHC1 TFCP2L1 PER3 MTA3 ATF1 KDM6A MYBL2	3.14e-07	808	183	18	20412781
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	FOXO3 SHROOM3 TSHZ2 TNRC6C ZNF236 ARID1A CCDC57 CREBBP SH2B1 PKNOX2 PACS1 CFAP20DC USF3 MTA3 NFIA PURA DLG1 MACF1 CSMD1 KDM6A SLC4A5 MAML3 EP300 WNK2 AGAP3	3.19e-07	1489	183	25	28611215
Pubmed	Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes.	POM121C POM121 POM121B	5.71e-07	4	183	3	17900573
Pubmed	MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis.	CREBBP KMT2D EP300	5.71e-07	4	183	3	28398509
Pubmed	Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.	ARID1A KMT2D KDM6A	5.71e-07	4	183	3	26138514
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	PARK7 MAML1 NUP58 ARID1A WNK1 CREBBP POTEE ATF7IP TNRC6A MED25 MACF1 POTEI SIPA1L2 SLX4 MYBL2	5.97e-07	588	183	15	38580884
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ZEB1 MYO1C BCL9 REXO1 PACS1 KMT2D MTA1 NFIA TMPO SMARCC2 DLG1 MN1 KDM6A BAG6 CSTF2T HOMEZ MYBL2	8.25e-07	774	183	17	15302935
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DENND2A SHROOM3 PIEZO1 MAML1 CRTC1 NUP58 KIAA1614 MYEF2 MTA3 TNRC6A NAV2 PCNX1 WNK2 HOMEZ	9.33e-07	529	183	14	14621295
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	ZEB1 ZBTB48 MED13L ARID1A MIDEAS CREBBP PHC1 SLC25A22 SS18L1 MED25 SMARCC2 EP300 SLX4	9.46e-07	453	183	13	29656893
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	BCL9L ZBTB48 ARID1A KMT2D MTA1 MTA3 TNRC6A SMARCC2 LSM14B TASOR KDM6A BAG6 HYDIN	1.39e-06	469	183	13	27634302
Pubmed	Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation.	SP3 CREBBP EP300	1.42e-06	5	183	3	10362258
Pubmed	Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins.	ZEB1 CREBBP EP300	1.42e-06	5	183	3	12743039
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	ZEB1 MAML1 SIX4 ARID1A CREBBP KMT2D ATF7IP TMPO SMARCC2 BICRAL KDM6A EP300	1.51e-06	398	183	12	35016035
Pubmed	Peering through the pore: nuclear pore complex structure, assembly, and function.	SEH1L NUP58 POM121C POM121 POM121B	1.66e-06	38	183	5	12791264
Pubmed	Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1.	ARID1A CREBBP SMARCC2 KDM6A EP300	2.16e-06	40	183	5	34585037
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZEB1 CRTC1 IDH3A PHC1 KMT2D EIF4ENIF1 ATF7IP TNRC6A TASOR CSTF2T HOMEZ MYBL2	2.50e-06	418	183	12	34709266
Pubmed	Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination.	PADI4 CREBBP EP300	2.83e-06	6	183	3	15731352
Pubmed	Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation.	CRTC1 CREBBP EP300	2.83e-06	6	183	3	15961999
Pubmed	Sp1 family of transcription factors regulates the human alpha2 (XI) collagen gene (COL11A2) in Saos-2 osteoblastic cells.	SP3 CREBBP EP300	2.83e-06	6	183	3	16734381
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	FOXO3 FOXO3B TRO MAML1 FBXO11 SIX4 CREBBP CREM SH2B1 MYEF2 KMT2D MTA1 NFIA SMARCC2 ATF1 EP300 MYBL2	3.25e-06	857	183	17	25609649
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	FOXO3 SHROOM3 EDC3 POTEF HJURP SIK1 CRTC1 WNK1 MEX3C KSR1 MEGF8 NAV2 MACF1 SIPA1L2 DMTN TNS3 AGAP3	3.46e-06	861	183	17	36931259
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	ZNF410 ZBTB48 MAML1 VSX1 ZNF236 CREBBP NCOA5 PKNOX2 TFCP2L1 HOXD3 MZF1 PURA SS18L1 MAML3 EP300 VGLL1 MYBL2	4.41e-06	877	183	17	20211142
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	FOXO3 BCL9L SHROOM3 EDC3 ARID1A WNK1 KSR1 EIF4ENIF1 TNRC6A SIPA1L2 DMTN AGAP3	4.83e-06	446	183	12	24255178
Pubmed	Aldo-keto reductase 1b7, a novel marker for renin cells, is regulated by cyclic AMP signaling.	REN CREBBP EP300	4.94e-06	7	183	3	26180185
Pubmed	LPCAT3 Is Transcriptionally Regulated by YAP/ZEB/EP300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity.	ZEB1 KMT2D EP300	4.94e-06	7	183	3	37166352
Pubmed	Rare De Novo Missense Variants in RNA Helicase DDX6 Cause Intellectual Disability and Dysmorphic Features and Lead to P-Body Defects and RNA Dysregulation.	EDC3 EIF4ENIF1 LSM14B	4.94e-06	7	183	3	31422817
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	KLF12 EDC3 FN1 GAS2L3 HJURP MARCHF7 FBXO11 CRTC1 GOLM1 WNK1 REPIN1 PACS1 ALKBH8 MTA1 DLG1 MACF1 HERC1 TASOR SLX4	5.03e-06	1084	183	19	11544199
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	UBQLN2 HMGCR WDR74 EIF4ENIF1 PURA TNRC6A SIPA1L2 TASOR MYBL2	5.99e-06	242	183	9	34011540
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	SOX1 COMP GAS2L3 PARK7 HJURP MED13L PHGDH MYEF2 MEX3C YTHDF1 YOD1 TNRC6A NAV2 LSM14B SIPA1L2	8.58e-06	732	183	15	34732716
Pubmed	Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes.	ZEB1 ARID1A MYEF2 MTA1 SMARCC2	8.93e-06	53	183	5	21532573
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	FOXO3 EDC3 MAML1 MARCHF7 SIK1 CRTC1 TNRC6C WNK1 PHGDH MEX3C YTHDF1 WDR74 KSR1 EIF4ENIF1 NFIA SNRNP40 LSM14B TNS3	1.04e-05	1038	183	18	26673895
Pubmed	Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significance.	COMP CRTC1 CSMD1	1.18e-05	9	183	3	25057126
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	FAT4 UBQLN2 TRO MARCHF7 WNK1 POM121 EIF4ENIF1 MEGF8 TMPO SMARCC2 BAG6 CSTF2T WNK2	2.24e-05	608	183	13	16713569
Pubmed	Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.	FAT4 FBXO11 CREBBP	2.29e-05	11	183	3	24349473
Pubmed	Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program.	ARID1A CREBBP SMARCC2	2.29e-05	11	183	3	18003620
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	EDC3 ZNF628 HJURP TNRC6C YTHDF1 POTEE PURA TNRC6A LSM14B BAG6	2.54e-05	364	183	10	24778252
Pubmed	Loss of p300 accelerates MDS-associated leukemogenesis.	CREBBP EP300	2.75e-05	2	183	2	27881875
Pubmed	Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.	CREBBP EP300	2.75e-05	2	183	2	34845315
Pubmed	p300 plays a critical role in maintaining cardiac mitochondrial function and cell survival in postnatal hearts.	CREBBP EP300	2.75e-05	2	183	2	19729597
Pubmed	Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study.	HMGCR NPC1L1	2.75e-05	2	183	2	25770315
Pubmed	Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome.	KMT2D KDM6A	2.75e-05	2	183	2	24739679
Pubmed	Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors.	ADORA2A ADORA2B	2.75e-05	2	183	2	21480628
Pubmed	CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer.	CREBBP EP300	2.75e-05	2	183	2	39287984
Pubmed	Molecular cloning of FKHRL1P2, a member of the developmentally regulated fork head domain transcription factor family.	FOXO3 FOXO3B	2.75e-05	2	183	2	9852958
Pubmed	Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders.	KMT2D KDM6A	2.75e-05	2	183	2	31935506
Pubmed	Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor.	ADORA2A ADORA2B	2.75e-05	2	183	2	18465770
Pubmed	Update of the genotype and phenotype of KMT2D and KDM6A by genetic screening of 100 patients with clinically suspected Kabuki syndrome.	KMT2D KDM6A	2.75e-05	2	183	2	32803813
Pubmed	Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH.	CREBBP EP300	2.75e-05	2	183	2	20717166
Pubmed	The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.	CREBBP EP300	2.75e-05	2	183	2	25893291
Pubmed	Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.	CREBBP EP300	2.75e-05	2	183	2	11559821
Pubmed	A primate-specific POTE-actin fusion protein plays a role in apoptosis.	POTEF POTEE	2.75e-05	2	183	2	19669888
Pubmed	Differential effects of adenosine A2a and A2b receptors on cardiac contractility.	ADORA2A ADORA2B	2.75e-05	2	183	2	20935155
Pubmed	PER3 and ADORA2A polymorphisms impact neurobehavioral performance during sleep restriction.	ADORA2A PER3	2.75e-05	2	183	2	23171222
Pubmed	Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions.	BCL9L BCL9	2.75e-05	2	183	2	15371335
Pubmed	Activation of adenosine A2A or A2B receptors causes hypothermia in mice.	ADORA2A ADORA2B	2.75e-05	2	183	2	29548686
Pubmed	CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas.	CREBBP EP300	2.75e-05	2	183	2	32576962
Pubmed	Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.	CREBBP EP300	2.75e-05	2	183	2	19822209
Pubmed	Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.	KMT2D KDM6A	2.75e-05	2	183	2	23184418
Pubmed	A specific CBP/p300-dependent gene expression programme drives the metabolic remodelling in late stages of spermatogenesis.	CREBBP EP300	2.75e-05	2	183	2	24522976
Pubmed	CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement.	CREBBP EP300	2.75e-05	2	183	2	21847097
Pubmed	Conserved and distinct modes of CREB/ATF transcription factor regulation by PP2A/B56gamma and genotoxic stress.	CREBBP ATF1	2.75e-05	2	183	2	20730097
Pubmed	Extracellular adenosine regulates naive T cell development and peripheral maintenance.	ADORA2A ADORA2B	2.75e-05	2	183	2	24145516
Pubmed	Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury.	ADORA2A ADORA2B	2.75e-05	2	183	2	19299692
Pubmed	p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes.	CREBBP EP300	2.75e-05	2	183	2	34813504
Pubmed	Rubinstein-Taybi Syndrome	CREBBP EP300	2.75e-05	2	183	2	20301699
Pubmed	Galectin-9 Is a Possible Promoter of Immunopathology in Rheumatoid Arthritis by Activation of Peptidyl Arginine Deiminase 4 (PAD-4) in Granulocytes.	PADI4 LGALS9	2.75e-05	2	183	2	31430907
Pubmed	Potential biomarker of metformin action.	CREBBP EP300	2.75e-05	2	183	2	24639469
Pubmed	The histone acetyl transferases CBP and p300 regulate stress response pathways in synovial fibroblasts at transcriptional and functional levels.	CREBBP EP300	2.75e-05	2	183	2	37816914
Interaction	NUP35 interactions	SEH1L BCL9L MAML1 NUP58 BCL9 ARID1A POM121C MIDEAS CREBBP PHGDH MYEF2 SLC30A6 NCOA5 YTHDF1 KMT2D POM121 EIF4ENIF1 FAM222B TNRC6A TMPO MAML3 EP300	2.72e-11	424	178	22	int:NUP35
Interaction	TBXT interactions	MAML1 SIX4 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA SS18L1 SMARCC2 KDM6A EP300 HOMEZ	3.20e-11	116	178	13	int:TBXT
Interaction	FEV interactions	ZEB1 MAML1 SIX4 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA SS18L1 ATF1 KDM6A EP300 HOMEZ MYBL2	3.74e-10	203	178	15	int:FEV
Interaction	GCM1 interactions	BCL9 ARID1A MIDEAS CREBBP YTHDF1 KMT2D NFIA SMARCC2 KDM6A EP300	4.19e-10	68	178	10	int:GCM1
Interaction	PAX7 interactions	ZEB1 MAML1 SIX4 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA SS18L1 KDM6A EP300	1.05e-09	124	178	12	int:PAX7
Interaction	HNF1B interactions	ZEB1 MAML1 SIX4 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA ATF7IP TMPO ATF1 KDM6A EP300	1.53e-09	190	178	14	int:HNF1B
Interaction	SOX2 interactions	SOX1 BCL9L ZEB1 FN1 COMP MYO1C GAS2L3 PARK7 HJURP MAML1 FAHD2A SIX4 MED13L BCL9 ARID1A MIDEAS PHGDH MYEF2 MEX3C YTHDF1 YOD1 KMT2D MTA1 MTA3 NFIA TNRC6A NAV2 TMPO SMARCC2 MACF1 ATF1 LSM14B SIPA1L2 KDM6A EP300 HOMEZ MYBL2	2.18e-09	1422	178	37	int:SOX2
Interaction	EGR2 interactions	BCL9L MAML1 SIX4 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA SS18L1 KDM6A EP300 HOMEZ	4.10e-09	171	178	13	int:EGR2
Interaction	NFIA interactions	KLF12 MAML1 SIX4 VSX1 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA SNRNP40 KDM6A EP300	1.29e-08	188	178	13	int:NFIA
Interaction	SOX9 interactions	BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA SMARCC2 HERC1 KDM6A EP300	1.45e-08	97	178	10	int:SOX9
Interaction	PAX8 interactions	MAML1 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA SS18L1 KDM6A EP300	5.35e-08	111	178	10	int:PAX8
Interaction	TOP3B interactions	FOXO3 SHROOM3 ZNF628 MYO1C PIEZO1 MAML1 TNRC6C MED13L BCL9 ZNF236 ARID1A POM121C WNK1 REPIN1 ABCA7 REXO1 ADCY7 PHGDH CCDC142 YTHDF1 SLC25A22 KMT2D EIF4ENIF1 MEGF8 CSPG4 SNRNP40 NAV2 PCNX1 HERC1 LSM14B SIPA1L2 EP300 WNK2 MYBL2 AGAP3	6.01e-08	1470	178	35	int:TOP3B
Interaction	SP7 interactions	BCL9L MAML1 SIX4 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA SS18L1 SMARCC2 KDM6A EP300 HOMEZ MYBL2	8.84e-08	304	178	15	int:SP7
Interaction	ERG interactions	MAML1 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA ATF7IP SS18L1 SMARCC2 KDM6A EP300 SLX4	9.73e-08	223	178	13	int:ERG
Interaction	PAX6 interactions	ZNF410 ZEB1 SIX4 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA SS18L1 SMARCC2 DLG1 KDM6A EP300 HOMEZ MYBL2	1.70e-07	366	178	16	int:PAX6
Interaction	PAX9 interactions	BCL9L MAML1 BCL9 ARID1A MIDEAS KMT2D NFIA KDM6A EP300 HOMEZ	2.40e-07	130	178	10	int:PAX9
Interaction	CREBBP interactions	FOXO3 SP3 ZEB1 MAML1 CRTC1 ARID1A CREBBP CREM KMT2D EIF4ENIF1 NFIA ATF7IP SS18L1 MED25 SMARCC2 ATF1 KDM6A EP300 SLX4 MYBL2	3.68e-07	599	178	20	int:CREBBP
Interaction	CRX interactions	BCL9L SP3 MAML1 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA SS18L1 KDM6A EP300 HOMEZ	4.36e-07	254	178	13	int:CRX
Interaction	TLX1 interactions	MAML1 SIX4 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA KDM6A EP300 HOMEZ	4.58e-07	175	178	11	int:TLX1
Interaction	NFIB interactions	KLF12 MAML1 VSX1 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA KDM6A	5.45e-07	142	178	10	int:NFIB
Interaction	TBR1 interactions	BCL9L MAML1 BCL9 ARID1A MIDEAS KMT2D NFIA KDM6A EP300	7.25e-07	113	178	9	int:TBR1
Interaction	GATA3 interactions	SIX4 BCL9 ARID1A MIDEAS REPIN1 CREBBP KMT2D MTA3 NFIA KDM6A EP300	8.86e-07	187	178	11	int:GATA3
Interaction	GSC interactions	BCL9L BCL9 MIDEAS CREBBP KMT2D NFIA KDM6A EP300	1.02e-06	87	178	8	int:GSC
Interaction	MYOD1 interactions	ZEB1 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA SS18L1 SMARCC2 KDM6A EP300	1.27e-06	194	178	11	int:MYOD1
Interaction	TLE3 interactions	BCL9L MAML1 SIX4 VSX1 BCL9 ARID1A MIDEAS CREBBP KMT2D POM121 NFIA TNRC6A SMARCC2 EP300 MYBL2	1.32e-06	376	178	15	int:TLE3
Interaction	DTX2 interactions	BCL9L SHROOM3 NUP58 BCL9 POM121C CCDC57 SLC30A6 NCOA5 EIF4ENIF1 NFIA TNRC6A TMPO BICRAL TASOR	1.47e-06	330	178	14	int:DTX2
Interaction	FOXI1 interactions	BCL9 ARID1A CREBBP KMT2D NFIA KDM6A EP300 CSTF2T	1.57e-06	92	178	8	int:FOXI1
Interaction	GATA2 interactions	ZEB1 SIX4 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA SMARCC2 KDM6A EP300	1.63e-06	199	178	11	int:GATA2
Interaction	EYA4 interactions	SEH1L UBQLN2 MAML1 TNRC6C SIX4 BCL9 MIDEAS CREBBP WDR74 FAM222B TNRC6A EP300	1.78e-06	243	178	12	int:EYA4
Interaction	MARF1 interactions	PRICKLE4 EDC3 POM121C CREBBP YTHDF1 POM121 EIF4ENIF1 TNRC6A LSM14B	2.07e-06	128	178	9	int:MARF1
Interaction	TFCP2L1 interactions	ARID1A MIDEAS PHC1 TFCP2L1 MTA1 MTA3 SMARCC2 MYBL2	2.73e-06	99	178	8	int:TFCP2L1
Interaction	LHX3 interactions	SIX4 BCL9 ARID1A MIDEAS CREBBP KMT2D NFIA SS18L1 KDM6A MYBL2	5.99e-06	185	178	10	int:LHX3
Interaction	HNF4A interactions	ARID1A MIDEAS CREBBP KMT2D NFIA ATF7IP SS18L1 SMARCC2 KDM6A EP300 SLX4 MYBL2	6.37e-06	275	178	12	int:HNF4A
Interaction	SOX7 interactions	MAML1 ARID1A CREBBP KMT2D SMARCC2 KDM6A EP300	8.11e-06	82	178	7	int:SOX7
Interaction	HDAC2 interactions	SP3 PADI4 ZEB1 EDC3 CYBRD1 PARK7 ARID1A WNK1 MIDEAS REPIN1 CREBBP PHC1 TFCP2L1 MTA1 MTA3 SS18L1 SNRNP40 TMPO SMARCC2 KDM6A EP300 MYBL2	8.29e-06	865	178	22	int:HDAC2
Interaction	MYBL2 interactions	HJURP CREBBP TFCP2L1 MTA1 MTA3 SNRNP40 EP300 SLX4 MYBL2	1.42e-05	162	178	9	int:MYBL2
Interaction	E2F5 interactions	ARID1A CREBBP KMT2D EP300 MYBL2	1.53e-05	36	178	5	int:E2F5
Interaction	KLF1 interactions	ARID1A CCDC57 CREBBP SMARCC2 EP300	1.76e-05	37	178	5	int:KLF1
Interaction	FOS interactions	ZEB1 MYO1C TRO BCL9 ARID1A CREBBP KMT2D NFIA SS18L1 SMARCC2 KDM6A EP300	2.25e-05	312	178	12	int:FOS
Interaction	TEAD1 interactions	ZEB1 ARID1A MIDEAS CREBBP KMT2D NFIA KDM6A EP300 VGLL1	2.74e-05	176	178	9	int:TEAD1
Interaction	GATAD2A interactions	KLF12 HJURP CREBBP TFCP2L1 MTA1 MTA3 TNRC6A SNRNP40 SMARCC2 MYBL2	3.15e-05	224	178	10	int:GATAD2A
Interaction	ETV4 interactions	BCL9 ARID1A CREBBP KMT2D KDM6A EP300	3.30e-05	69	178	6	int:ETV4
Interaction	ARID1A interactions	FOXO3 TEX13B ARID1A CREBBP TFCP2L1 NFIA SS18L1 TNRC6A SNRNP40 SMARCC2 EP300	3.60e-05	276	178	11	int:ARID1A
Interaction	LOC254896 interactions	FAT4 EDC3 POTEF TSC22D2 CSPG4	3.73e-05	43	178	5	int:LOC254896
Interaction	CEBPA interactions	SEH1L MAML1 MED13L BCL9 ARID1A MIDEAS CREBBP PHGDH NCOA5 WDR74 KMT2D MTA1 MTA3 SNRNP40 TMPO SMARCC2 MACF1 BICRAL ATF1 LSM14B KDM6A BAG6 EP300 CSTF2T HOMEZ MYBL2	3.78e-05	1245	178	26	int:CEBPA
Interaction	YWHAH interactions	FOXO3 SHROOM3 EDC3 FN1 POTEF HJURP SIK1 CRTC1 WNK1 CREBBP MEX3C PACS1 KSR1 MEGF8 PURA NAV2 MACF1 HERC1 SIPA1L2 WNK2 DMTN TNS3 HOMEZ AGAP3	4.02e-05	1102	178	24	int:YWHAH
Interaction	MTA1 interactions	TSHZ2 PARK7 HJURP TFCP2L1 MTA1 MTA3 SNRNP40 SMARCC2 BAG6 EP300 MYBL2	4.52e-05	283	178	11	int:MTA1
Interaction	MAML1 interactions	MAML1 CREBBP NFIA MAML3 EP300 SLX4	4.55e-05	73	178	6	int:MAML1
Interaction	CPEB1 interactions	EDC3 TNRC6C YTHDF1 EIF4ENIF1 PURA TNRC6A LSM14B CSTF2T	4.73e-05	146	178	8	int:CPEB1
Interaction	ELF5 interactions	ARID1A MIDEAS MYEF2 KMT2D SS18L1 SNRNP40 KDM6A EP300	4.97e-05	147	178	8	int:ELF5
Interaction	GPBP1 interactions	TNRC6C TSC22D2 CCDC57 CREBBP TNRC6A EP300	5.30e-05	75	178	6	int:GPBP1
Interaction	TLX3 interactions	BCL9L MAML1 BCL9 ARID1A MIDEAS KMT2D NFIA ITIH6 KDM6A EP300 HOMEZ	5.81e-05	291	178	11	int:TLX3
Interaction	TFAP4 interactions	SP3 ARID1A MIDEAS TFCP2L1 MTA3 NFIA SMARCC2 ATF1	6.59e-05	153	178	8	int:TFAP4
Interaction	SMARCD1 interactions	TEX13B ARID1A PKNOX2 TFCP2L1 HOXD3 NFIA COG6 SS18L1 TNRC6A SMARCC2 BICRAL HOMEZ	6.66e-05	349	178	12	int:SMARCD1
Interaction	CPEB4 interactions	EDC3 UBQLN2 TNRC6C YTHDF1 EIF4ENIF1 TNRC6A CSTF2T HOMEZ	7.56e-05	156	178	8	int:CPEB4
Interaction	BMI1 interactions	PARK7 REPIN1 CREBBP PHGDH MYEF2 PHC1 NCOA5 YTHDF1 POTEE PURA SS18L1 TMPO ATF1 LSM14B TASOR KDM6A EP300	7.89e-05	659	178	17	int:BMI1
Interaction	SOWAHA interactions	POM121C CREBBP POM121 EIF4ENIF1	8.81e-05	27	178	4	int:SOWAHA
Interaction	RBPJ interactions	MAML1 TNFRSF11A CREBBP CREM MTA3 NFIA SMARCC2 ATF1 MAML3 EP300	9.05e-05	254	178	10	int:RBPJ
Interaction	USP7 interactions	FOXO3 SP3 KLF12 PADI4 ZEB1 TRO MARCHF7 TSC22D2 CREBBP C5orf47 PHGDH MEX3C LGALS9 WDR74 KMT2D NAV2 TMPO SMARCC2 MACF1 UMPS HERC1 KDM6A SLC4A5 BAG6 EP300 DMTN	9.11e-05	1313	178	26	int:USP7
Interaction	MBD2 interactions	HJURP ARID1A CREBBP TFCP2L1 MTA1 MTA3 SMARCC2 MYBL2	9.42e-05	161	178	8	int:MBD2
Interaction	ETS1 interactions	ARID1A CREBBP KMT2D SS18L1 SMARCC2 KDM6A EP300	1.01e-04	121	178	7	int:ETS1
Interaction	EP300 interactions	FOXO3 SP3 KLF12 ZEB1 EDC3 ZBTB48 MAML1 CRTC1 HMGCR IDH3A ARID1A CREBBP PHGDH ZNF469 KMT2D MTA1 NFIA PURA SS18L1 TMPO SMARCC2 UMPS HERC1 MN1 BAG6 EP300 MYBL2	1.04e-04	1401	178	27	int:EP300
Interaction	PAX2 interactions	MAPK8IP1 BCL9 MIDEAS KMT2D NFIA KDM6A	1.07e-04	85	178	6	int:PAX2
Interaction	NFIC interactions	SIX4 ARID1A MIDEAS CREBBP KMT2D NFIA SNRNP40 KDM6A HOMEZ	1.08e-04	210	178	9	int:NFIC
Interaction	YWHAE interactions	FOXO3 SHROOM3 EDC3 FN1 POTEF HJURP SIK1 CRTC1 COL6A5 WNK1 MEX3C LGALS9 PACS1 KSR1 SLC8A3 PURA NAV2 TMPO SMARCC2 MACF1 SIPA1L2 WNK2 DMTN GPRIN2 AGAP3	1.16e-04	1256	178	25	int:YWHAE
Interaction	SMG7 interactions	EDC3 MAML1 TNRC6C SIX4 BCL9 ARID1A CREBBP YTHDF1 KMT2D EIF4ENIF1 TNRC6A	1.31e-04	319	178	11	int:SMG7
Interaction	TPRX2 interactions	ARID1A CREBBP KMT2D SMARCC2 KDM6A	1.35e-04	56	178	5	int:TPRX2
Interaction	SPATA1 interactions	NUP58 WNK1 EP300 WNK2	1.54e-04	31	178	4	int:SPATA1
Interaction	ZMYM2 interactions	KLF12 TSC22D2 SIX4 CREBBP MTA1 ATF7IP SIMC1 SLX4 HOMEZ MYBL2	1.54e-04	271	178	10	int:ZMYM2
Interaction	IRF8 interactions	BCL9 KMT2D NFIA KDM6A MYBL2	1.59e-04	58	178	5	int:IRF8
Interaction	SOX10 interactions	BCL9 ARID1A KMT2D NFIA KDM6A EP300	1.66e-04	92	178	6	int:SOX10
Interaction	ALPG interactions	POTEF MEGF8 GUSB CSPG4	1.74e-04	32	178	4	int:ALPG
Interaction	GIGYF1 interactions	EDC3 TSHZ2 TNRC6C CCDC57 KSR1 EIF4ENIF1 TNRC6A DACT3	1.81e-04	177	178	8	int:GIGYF1
Interaction	AR interactions	BCL9L FN1 MYO1C PARK7 MAML1 SH2D2A MED13L BCL9 ARID1A MIDEAS CREBBP PHGDH MYEF2 KMT2D MTA1 MTA3 NFIA SMARCC2 KDM6A BAG6 EP300	1.87e-04	992	178	21	int:AR
Interaction	NFIX interactions	ZEB1 SIX4 ARID1A MIDEAS KMT2D NFIA SMARCC2 KDM6A MYBL2	1.93e-04	227	178	9	int:NFIX
Interaction	SOX17 interactions	BCL9 ARID1A MIDEAS KMT2D NFIA KDM6A	1.98e-04	95	178	6	int:SOX17
Interaction	KLF3 interactions	ZEB1 ARID1A MIDEAS KMT2D MTA3 NFIA ATF7IP KDM6A EP300	2.00e-04	228	178	9	int:KLF3
Interaction	ALG13 interactions	BCL9 ARID1A NCOA5 YTHDF1 KMT2D EIF4ENIF1 TNRC6A EP300	2.28e-04	183	178	8	int:ALG13
Interaction	LHX2 interactions	BCL9L BCL9 ARID1A KMT2D NFIA SMARCC2 KDM6A HOMEZ	2.28e-04	183	178	8	int:LHX2
Interaction	SS18L1 interactions	ARID1A CREBBP SS18L1 SMARCC2 BICRAL EP300	2.35e-04	98	178	6	int:SS18L1
Interaction	SMARCA4 interactions	ZEB1 MAML1 ARID1A CREBBP MYEF2 TFCP2L1 SS18L1 SNRNP40 SMARCC2 BICRAL KDM6A EP300 SLX4	2.45e-04	462	178	13	int:SMARCA4
Interaction	SOX15 interactions	SIX4 BCL9 ARID1A KMT2D NFIA KDM6A EP300	2.61e-04	141	178	7	int:SOX15
Interaction	HOXB2 interactions	ZNF410 CREBBP KMT2D EP300	2.78e-04	36	178	4	int:HOXB2
Interaction	HDAC1 interactions	SP3 PADI4 ZEB1 CYBRD1 FN1 PARK7 CRTC1 ARID1A MIDEAS REPIN1 CREBBP CREM TFCP2L1 KMT2D MTA1 EIF4ENIF1 MTA3 TNRC6A SMARCC2 TASOR EP300 CSTF2T	3.19e-04	1108	178	22	int:HDAC1
Interaction	SMAD1 interactions	FOXO3 ZEB1 ARID1A CREBBP KMT2D EIF4ENIF1 SS18L1 MED25 EP300	3.20e-04	243	178	9	int:SMAD1
Interaction	MDC1 interactions	UBQLN2 ARID1A MIDEAS CREBBP PHGDH PHC1 SLC25A22 TNRC6A SNRNP40 SMARCC2 EP300 SLX4	3.25e-04	414	178	12	int:MDC1
Interaction	GATAD2B interactions	PARK7 HJURP ARID1A TFCP2L1 MTA1 MTA3 SMARCC2 SLX4 MYBL2	3.40e-04	245	178	9	int:GATAD2B
Interaction	KLF5 interactions	MAML1 BCL9 ARID1A CREBBP KMT2D NFIA KDM6A EP300	3.49e-04	195	178	8	int:KLF5
Interaction	LASP1 interactions	UBQLN2 FN1 MYO1C SH2D2A ARHGEF15 YTHDF1 MED25 EP300 CSTF2T	3.61e-04	247	178	9	int:LASP1
Interaction	NR3C1 interactions	FAT4 GAS2L3 SLC25A34 MAML1 BCL9 ARID1A POM121C CREBBP PHGDH MYEF2 KMT2D MEGF8 NFIA SS18L1 MED25 SMARCC2 KDM6A MAML3 EP300 MYBL2	3.96e-04	974	178	20	int:NR3C1
Interaction	PEF1 interactions	UBQLN2 MED25 BAG6 HYDIN SLX4 CSTF2T	3.97e-04	108	178	6	int:PEF1
Interaction	ATXN7 interactions	UBQLN2 FN1 MEGF8 COG6 EP300 SLX4	4.17e-04	109	178	6	int:ATXN7
Interaction	MAML2 interactions	MAML1 CREBBP EP300	4.21e-04	17	178	3	int:MAML2
Interaction	EN1 interactions	ZEB1 MIDEAS KMT2D NFIA KDM6A EP300	4.37e-04	110	178	6	int:EN1
Interaction	HOXB1 interactions	CREBBP ZNF835 PKNOX2 EP300	4.62e-04	41	178	4	int:HOXB1
Interaction	TFF1 interactions	PADI4 CREBBP MED25 EP300	4.62e-04	41	178	4	int:TFF1
Interaction	B9D2 interactions	NUP58 NCOA5 YTHDF1 EIF4ENIF1 TASOR	4.70e-04	73	178	5	int:B9D2
Interaction	HELZ interactions	EDC3 TNRC6C POM121C CREBBP YTHDF1 POM121 EIF4ENIF1 TNRC6A TNXB	4.81e-04	257	178	9	int:HELZ
Interaction	SERPINI2 interactions	UBQLN2 NUP58 BAG6	5.01e-04	18	178	3	int:SERPINI2
Interaction	CNOT3 interactions	TNRC6C CREBBP MEX3C YTHDF1 EIF4ENIF1 TNRC6A EP300 AGAP3	5.20e-04	207	178	8	int:CNOT3
Cytoband	Xp11.22-p11.21	TRO ITIH6	9.43e-05	4	183	2	Xp11.22-p11.21
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTEF POTEB2 POTEE POTEI POTEB	1.08e-08	13	113	5	685
GeneFamily	Ataxins\|Trinucleotide repeat containing	TNRC6C KMT2D TNRC6A MAML3	1.65e-05	25	113	4	775
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MIDEAS MTA1 MTA3 SMARCC2 MYBL2	1.97e-05	53	113	5	532
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZEB1 TSHZ2 HOMEZ	1.02e-04	15	113	3	529
GeneFamily	Adenosine receptors	ADORA2A ADORA2B	2.30e-04	4	113	2	211
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF410 SP3 KLF12 ZEB1 ZNF628 ZBTB48 TSHZ2 ZNF805 ZNF236 REPIN1 ZNF835 ZNF469 MZF1	5.44e-04	718	113	13	28
GeneFamily	Nucleoporins	SEH1L NUP58 POM121	1.03e-03	32	113	3	1051
GeneFamily	PHD finger proteins\|NuRD complex	MTA1 MTA3	2.45e-03	12	113	2	1305
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MTA1 MTA3	3.85e-03	15	113	2	82
GeneFamily	Ankyrin repeat domain containing	POTEF POTEB2 POTEE POTEI POTEB AGAP3	4.15e-03	242	113	6	403
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP EP300	4.95e-03	17	113	2	486
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP EP300	5.55e-03	18	113	2	91
Coexpression	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP	SUPT20HL1 DENND2A PADI4 MARCHF7 GOLM1 NFIA GUSB TMPO ATF1 HERC1	4.81e-07	179	180	10	M8828
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	SP3 PARK7 SIK1 HMGCR IDH3A TSC22D2 MED13L ARID1A WNK1 REPIN1 CREBBP APLF KIAA1614 PKNOX2 PACS1 MTA3 NFIA ATF7IP SNRNP40 NAV2 MN1 CSTF2T TNS3	4.81e-07	1009	180	23	M157
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	ZNF410 FAT4 ZNF628 MARCHF7 HMGCR BCL9 WNK1 CREBBP ADIPOR1 NFIA TNRC6A MED25 SIPA1L2 TASOR	6.98e-06	484	180	14	MM999
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP	FOXO3 BCL9L TSC22D2 MIDEAS REXO1 KMT2D USF3 TNRC6A HERC1	7.65e-06	192	180	9	M8272
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP	FOXO3 MAML1 ABCA7 SH2B1 KMT2D MACF1 HERC1 TASOR TNXB	9.03e-06	196	180	9	M5381
Coexpression	GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	ZEB1 MAML1 MED13L WNK1 MIDEAS CREBBP ATF7IP TNRC6A RAPGEFL1	1.06e-05	200	180	9	M291
Coexpression	GRYDER_PAX3FOXO1_TOP_ENHANCERS	PARK7 SIK1 IDH3A TSC22D2 MED13L CREBBP APLF KIAA1614 PKNOX2 ATF7IP MN1 CSTF2T TNS3	1.23e-05	441	180	13	M172
Coexpression	BROWNE_HCMV_INFECTION_6HR_DN	TSC22D2 BCL9 ADCY7 ADORA2B BICRAL MN1 KDM6A CSTF2T	1.86e-05	164	180	8	M10311
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	ZNF410 FAT4 MARCHF7 HMGCR BCL9 WNK1 CREBBP ADIPOR1 NFIA TNRC6A MED25 SIPA1L2 TASOR	2.24e-05	467	180	13	M1347
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	ZEB1 ARID1A WNK1 CREBBP ATF7IP MACF1 HERC1 EP300	3.62e-05	180	180	8	M8239
Coexpression	HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE	FOXO3 PRICKLE4 GAS2L3 TNFSF13 SLC25A34 SIK1 HMGCR NUP58 IDH3A TSC22D2 MED13L MIDEAS KSR1 ADIPOR1 GUSB SIGLEC10 MED25 SIPA1L2 BAG6 MAML3 SLX4 TNS3	5.04e-05	1250	180	22	M41099
Coexpression	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP	MYO1C SH2B1 MEX3C PACS1 POM121 PER3 SMARCC2 HERC1	5.12e-05	189	180	8	M9978
Coexpression	BURTON_ADIPOGENESIS_12	SP3 ARID1A MYEF2 BPNT2	6.66e-05	32	180	4	M1558
Coexpression	BURTON_ADIPOGENESIS_12	SP3 ARID1A MYEF2 BPNT2	6.66e-05	32	180	4	MM668
Coexpression	GSE13306_RA_VS_UNTREATED_TCONV_UP	COL4A6 SP3 BCL9 MIDEAS NCOA5 YTHDF1 MTA1 PCNX1	7.61e-05	200	180	8	M3234
Coexpression	GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP	BCL9L ZNF628 FAHD2A SIK1 CREBBP NFIA PCNX1 MN1	7.61e-05	200	180	8	M3523
Coexpression	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	FBXO11 TSC22D2 PHGDH YTHDF1 TMPO	9.20e-05	66	180	5	M1752
Coexpression	GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	SIK1 MS4A12 SH2D2A TSC22D2 CREM ADORA2A ADORA2B	9.74e-05	154	180	7	M6695
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	SP3 UBQLN2 POM121C WNK1 BPNT2 POM121 SMARCC2 POM121B	1.00e-04	208	180	8	MM581
Coexpression	SENESE_HDAC3_TARGETS_DN	SEH1L BCL9L GAS2L3 TRO ADCY7 PHGDH KMT2D POM121 NFIA SMARCC2 MN1 TNS3 MYBL2	1.14e-04	548	180	13	M16859
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	FOXO3 TNFSF13 POM121C POM121 ATF7IP TMPO DLG1 TASOR	1.43e-04	219	180	8	M41199
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SEH1L PRICKLE4 SP3 PADI4 ZNF628 ABCA7 PHC1 MEX3C CCDC142	5.86e-08	180	182	9	62511d76d24b836839c3dcc2bf30485ffe9401e2
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSHZ2 YOD1 KSR1 TFCP2L1 DLG1 MACF1 WNK2 RAPGEFL1	7.61e-07	179	182	8	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	SEH1L PRICKLE4 SP3 PADI4 ZNF628 ABCA7 PHC1 CCDC142	8.62e-07	182	182	8	03992d0ae519795239e4f2cc8e63f33c4482de6a
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A2\|343B / Donor, Lineage, Cell class and subclass (all cells)	PRICKLE4 SP3 PADI4 ZNF628 PHC1 MEX3C CCDC142	1.28e-06	133	182	7	8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	FOXO3 ZEB1 CYBRD1 FN1 TSHZ2 NFIA NAV2 TNXB	1.39e-06	194	182	8	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	MED13L PACS1 NFIA TNRC6A DLG1 HERC1 KDM6A MAML3	1.68e-06	199	182	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	COL4A6 FAT4 MAML1 MED13L ARID1A WNK1 MN1 MYBL2	1.68e-06	199	182	8	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CRTC1 KIAA1614 ZNF835 PHC1 MEX3C ALKBH8 COG6 TCFL5	1.75e-06	200	182	8	36de49593cf6ff1c9229fcceb150c1d68658a360
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|367C / Donor, Lineage, Cell class and subclass (all cells)	UBQLN2 PYCARD-AS1 MYEF2 YTHDF1 EIF4ENIF1 FGFBP2 BICRAL	4.56e-06	161	182	7	f470b662566131dfe69a2fd01186ac8491196396
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PYCARD-AS1 SIK1 REN CSPG4 CSMD1 MAML3	5.15e-06	164	182	7	43630a448f4369fa9e4e3eccdf3b9f29cec16c39
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PYCARD-AS1 SIK1 REN CSPG4 CSMD1 MAML3	5.15e-06	164	182	7	108fbecb56d69a675d6ce6e826a873ae528f2fd7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PYCARD-AS1 SIK1 REN CSPG4 CSMD1 MAML3	5.15e-06	164	182	7	46208f18325976c89f572f6627aea0582142b92d
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DENND2A COMP TSHZ2 TNFRSF11A YTHDF1 HOXD3 DLG1	5.35e-06	165	182	7	50a8513d8d2630861499393a7f102b35366bad37
ToppCell	Endothelial-Endothelial-G\|Endothelial / shred on cell class and cell subclass (v4)	DENND2A FN1 TSHZ2 TNFRSF11A HOXD3 MZF1 DLG1	7.03e-06	172	182	7	644f8e42ee8d8996f6ae50cdf874559be55509fc
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSHZ2 NUP58 OIT3 PER3 TASOR TNXB MAML3	9.12e-06	179	182	7	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF410 CYBRD1 GAS2L3 HJURP HMGCR KY SLX4	1.02e-05	182	182	7	39f9b3eb22293cc27c6e175702c77d1eeb24fdc9
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DENND2A ZEB1 FN1 TSHZ2 PKNOX2 NFIA TNXB	1.02e-05	182	182	7	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	severe_influenza-RBC\|World / disease group, cell group and cell class (v2)	FOXO3 HJURP WNK1 YOD1 ADIPOR1 TNXB DMTN	1.21e-05	187	182	7	f846750575f318503d21ade30f5bfd2e1d4c84af
ToppCell	Influenza_Severe-RBC\|World / Disease group and Cell class	FOXO3 HJURP WNK1 YOD1 ADIPOR1 TNXB DMTN	1.25e-05	188	182	7	f0438e6a77ee1f0456cb65926685266fff470983
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	UBQLN2 PYCARD-AS1 MYEF2 YTHDF1 EIF4ENIF1 FGFBP2 BICRAL	1.39e-05	191	182	7	39ef8e1d7cc3ebb11717e8a55501515e3b72b177
ToppCell	Influenza_Severe-RBC\|Influenza_Severe / Disease group and Cell class	FOXO3 HJURP WNK1 YOD1 ADIPOR1 TNXB DMTN	1.44e-05	192	182	7	f19b6da3fd98da1a76d2570137a8f73a3850ebcb
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ADORA2A SLC8A3 OIT3 EIF4ENIF1 NFIA HYDIN MYBL2	1.44e-05	192	182	7	d6f656be2698bd215717d35f4e7ab727c08c61e0
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FOXO3 FBXO11 MED13L PCNX1 KDM6A MAML3 TNS3	1.49e-05	193	182	7	779276e775cb2492e8dd36436295a536084a6415
ToppCell	wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	FOXO3 WNK1 ABCA7 YOD1 HERC1 EP300 DMTN	1.49e-05	193	182	7	be75abfdf5301cf33df8ee9ed92504d44fdf19a6
ToppCell	severe_influenza-RBC\|severe_influenza / disease group, cell group and cell class (v2)	FOXO3 HJURP WNK1 YOD1 ADIPOR1 TNXB DMTN	1.49e-05	193	182	7	ffb0b3c2cce13b6891157f0fede2600f3938670e
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ZEB1 CYBRD1 FN1 TSHZ2 NFIA NAV2 TNXB	1.59e-05	195	182	7	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FOXO3 FAT4 FN1 TSHZ2 NFIA NAV2 TNS3	1.70e-05	197	182	7	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FOXO3 FAT4 FN1 TSHZ2 NFIA NAV2 TNS3	1.70e-05	197	182	7	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A FAT4 ZEB1 COMP TSHZ2 COL6A5 TNXB	1.70e-05	197	182	7	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A FAT4 ZEB1 FN1 COMP TSHZ2 TNXB	1.70e-05	197	182	7	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	Influenza-Influenza_Severe-Others-RBC\|Influenza_Severe / Disease, condition lineage and cell class	FOXO3 HJURP WNK1 YOD1 ADIPOR1 TNXB DMTN	1.81e-05	199	182	7	da0fec0a492bc3827d9066d2590bcd466cd45564
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A FAT4 ZEB1 FN1 COMP COL6A5 TNXB	1.87e-05	200	182	7	8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A FAT4 FN1 TSHZ2 PKNOX2 NAV2 TNXB	1.87e-05	200	182	7	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3\|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9	PHC1 KMT2D COG6 DLG1 ATF1 KDM6A	1.97e-05	135	182	6	ac20133d4a36f48338b45bffb13e842cb66f83ad
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAH3 TMIGD2 HMGCR CREM PHGDH HOMEZ	2.62e-05	142	182	6	ae495c8dd733f0fde66bddc281606543f21c0d4b
ToppCell	ICU-NoSEP-Lymphocyte-T_NK-Treg\|ICU-NoSEP / Disease, Lineage and Cell Type	MAPK8IP1 ZEB1 TSHZ2 TRO USP9Y ZNF835	4.93e-05	159	182	6	d065ec02a4f3672ba53d4fea66029f1ce68f367f
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HJURP MAML1 SIX4 BPNT2 KMT2D GPRIN2	5.86e-05	164	182	6	4307b002fb41ddfc7ab8a6bca66a60942c250052
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HJURP MAML1 SIX4 BPNT2 KMT2D GPRIN2	5.86e-05	164	182	6	1d84aa5b925f502ee9c5fa39714490f613a58028
ToppCell	Control-Hematopoietic_Meg-Ery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FOXO3 WNK1 ADORA2B YOD1 ADIPOR1 DMTN	6.92e-05	169	182	6	c2e2a7b89fe4a64d79efafdec037c4104f433061
ToppCell	Control-Hematopoietic_Meg-Ery-Erythroid\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FOXO3 WNK1 ADORA2B YOD1 ADIPOR1 DMTN	6.92e-05	169	182	6	df1fc1477bbbb285063b9b122b1ac84c87fd7fa8
ToppCell	Control-Hematopoietic_Meg-Ery-Erythroid-Erythroid\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FOXO3 WNK1 ADORA2B YOD1 ADIPOR1 DMTN	6.92e-05	169	182	6	92986559aa4a744e8b0487b0ae035cfb1fbf9890
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FAT4 COMP TRO ZNF835 YOD1 HERC1	7.62e-05	172	182	6	c6bc78fd63c9479a84ec0552b55c89750cad0fa5
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FAT4 COMP TRO ZNF835 YOD1 HERC1	7.62e-05	172	182	6	bfb87a281a9cf6ad45b310bf8104fc0ab382b549
ToppCell	Endothelial-B-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	DENND2A TSHZ2 TNFRSF11A HOXD3 TNXB DMTN	7.62e-05	172	182	6	8a527dff06d841a86c7eb04a1dd9630787294da4
ToppCell	Adult-Mesenchymal-pericyte_cell-D231\|Adult / Lineage, Cell type, age group and donor	DENND2A ZEB1 PKNOX2 KY CSPG4 DACT3	7.62e-05	172	182	6	858cee96c1c06160863b4adcd7023c0d678bd50f
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP3 TNFRSF11A TSC22D2 WNK1 MACF1 TASOR	7.87e-05	173	182	6	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP3 TNFRSF11A TSC22D2 WNK1 MACF1 TASOR	7.87e-05	173	182	6	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP3 TNFRSF11A TSC22D2 WNK1 MACF1 TASOR	7.87e-05	173	182	6	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	ASK452-Immune-B_cell\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	MAML1 CCDC142 FGFBP2 SS18L1 KDM6A MYBL2	8.12e-05	174	182	6	69723f5666abc3af5f0431901a60246c9915ef81
ToppCell	Mesenchymal_cells-Osteo-CAR\|Mesenchymal_cells / Lineage and Cell class	FAT4 PLB1 COMP CFAP20DC NAV2 TNS3	8.12e-05	174	182	6	430e3cd61bc2a471959faa40e817aa4dd7d82d28
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	FAHD2B NCOA5 USF3 ALKBH8 SIMC1 PCNX1	8.38e-05	175	182	6	f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCell	COVID-19-lung-RBC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PADI4 YOD1 SLC8A3 HERC1 DMTN MYBL2	8.38e-05	175	182	6	4c35292ad2ac712ba7516f27dd6eac6ba8fdd163
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)\|343B / Donor, Lineage, Cell class and subclass (all cells)	FAT4 COMP TRO ZNF835 PKNOX2 DACT3	8.93e-05	177	182	6	e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	FAT4 COMP TRO ZNF835 PKNOX2 DACT3	8.93e-05	177	182	6	43ba6f12c2fb32698a420bf799d46ac1b558f146
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	FOXO3 FN1 COMP NCOA5 LSM14B TNS3	9.21e-05	178	182	6	edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF15 MEX3C CCDC142 PER3 SS18L1 RAPGEFL1	9.49e-05	179	182	6	dd94ebe69ade6f51b94058abe066216f0de9feda
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COMP TSHZ2 HJURP TNFRSF11A HOXD3 DLG1	1.01e-04	181	182	6	b0fff0defba9aea6fba36e378b05a59986e2573a
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COMP TSHZ2 HJURP TNFRSF11A HOXD3 DLG1	1.01e-04	181	182	6	cc77ac0e223e012767222e45c5dcadc246d1aa7c
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COMP TSHZ2 HJURP TNFRSF11A HOXD3 DLG1	1.01e-04	181	182	6	ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa
ToppCell	wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	FOXO3 WNK1 YOD1 HERC1 EP300 DMTN	1.04e-04	182	182	6	0c77ef4556c1d1512ebe9077df858b28f9e38dd5
ToppCell	facs-Trachea-24m-Epithelial-glandular_epithelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A6 PLB1 SHROOM3 CYBRD1 TFCP2L1 SLC4A5	1.10e-04	184	182	6	61caaa31975e05c9a6512079c791fed5a9e2d39f
ToppCell	facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A6 PLB1 SHROOM3 CYBRD1 TFCP2L1 SLC4A5	1.10e-04	184	182	6	03da0f0f89f1ca5a3ccca1e22972f3129464e68e
ToppCell	facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A6 PLB1 SHROOM3 CYBRD1 TFCP2L1 SLC4A5	1.10e-04	184	182	6	9ed2a65a4ca0ebbbb89ace61027522f93369843d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KLF12 ZEB1 TSHZ2 TMIGD2 TNRC6C TNRC6A	1.10e-04	184	182	6	5350b58aa9979631228835d11eb45ddf81d08bff
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FOXO3B POTEF WNK1 POTEE ADIPOR1 DMTN	1.14e-04	185	182	6	9f1a790680caaf9c1ec35db5e4b7641497401179
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZEB1 FN1 TSHZ2 PKNOX2 NFIA TNXB	1.14e-04	185	182	6	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	FAT4 ZEB1 FN1 TSHZ2 PKNOX2 NFIA	1.17e-04	186	182	6	7def03dd856b765bd3f493288641981c4f7fd26e
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	CYBRD1 FN1 TSHZ2 NFIA NAV2 TNXB	1.21e-04	187	182	6	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic-erythrocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FOXO3 FOXO3B WNK1 YOD1 ADIPOR1 DMTN	1.21e-04	187	182	6	c4ba9dfedbcf0357a8627af03f4fe1770e985a03
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-erythrocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FOXO3 FOXO3B WNK1 YOD1 ADIPOR1 DMTN	1.21e-04	187	182	6	13023661c26aaf9e42262a4ff91f2fb26e8a3eaf
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	DENND2A FN1 PKNOX2 NAV2 MACF1 TNXB	1.21e-04	187	182	6	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	DENND2A FAT4 ZEB1 FN1 TSHZ2 TNXB	1.21e-04	187	182	6	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	MED13L ATF7IP MACF1 PCNX1 HERC1 KDM6A	1.24e-04	188	182	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Endothelial-B\|World / lung cells shred on cell class, cell subclass, sample id	DENND2A ZEB1 TSHZ2 TNFRSF11A HOXD3 TNXB	1.24e-04	188	182	6	5959a88728812a5f4cbfa54eddc7a73ccbaa2f68
ToppCell	COVID-19-kidney-DCT\|kidney / Disease (COVID-19 only), tissue and cell type	SHROOM3 TSC22D2 WNK1 TFCP2L1 HOXD3 NAV2	1.24e-04	188	182	6	df1fd0819d301679f3c9ea404e942e39095912eb
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-chondrocyte\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FN1 COMP TSHZ2 FGFBP2 CSPG4 ITIH6	1.24e-04	188	182	6	5a89587ee6f2b4dc14244bd88bb31efb81c50dbe
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A TSC22D2 WNK1 TFCP2L1 HOXD3 NAV2	1.28e-04	189	182	6	975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A TSC22D2 WNK1 TFCP2L1 HOXD3 NAV2	1.28e-04	189	182	6	7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A TSC22D2 WNK1 TFCP2L1 HOXD3 NAV2	1.28e-04	189	182	6	55420853f730b433ef58ac9337ac84ac78a247a0
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	UBQLN2 PYCARD-AS1 MYEF2 YTHDF1 EIF4ENIF1 BICRAL	1.32e-04	190	182	6	2434b8ad2976eab7d9147012c28454ab29670709
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	DENND2A ZEB1 TSHZ2 TNFRSF11A HOXD3 TNXB	1.32e-04	190	182	6	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KLF12 ZEB1 TSHZ2 TMIGD2 TNRC6C TNRC6A	1.35e-04	191	182	6	d9a6f61fcda4f5352488f7f55cb9b57aeacc717f
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A FAT4 PKNOX2 NAV2 MACF1 TNXB	1.35e-04	191	182	6	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	COPD-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	ZEB1 SIK1 CREM WDR74 CSMD1 MAML3	1.39e-04	192	182	6	984cdc2f1d93e164bc946d63f58dacb629f82eb7
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZEB1 TSHZ2 OIT3 NFIA TNS3 RAPGEFL1	1.39e-04	192	182	6	6806a1a9fe00395dc1abc3e0124b4261dc701f31
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	DENND2A FAT4 TSHZ2 NFIA MN1 TNXB	1.39e-04	192	182	6	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FOXO3 WNK1 YOD1 ADIPOR1 TNXB DMTN	1.43e-04	193	182	6	305e15ee467826ee08b2617c69f250ad39c11b19
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	DENND2A FAT4 ZEB1 FN1 COMP TSHZ2	1.43e-04	193	182	6	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	TSHZ2 POTEF MTA3 TNRC6A DLG1 WNK2	1.43e-04	193	182	6	503a979328c68b096680b71359a26f02fafdff35
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CCL\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAHD2B SLC25A22 NPC1L1 MED25 UMPS CSTF2T	1.43e-04	193	182	6	21a117cceb562439ca3fe129aad8cac5f5728b1f
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FOXO3 WNK1 YOD1 ADIPOR1 TNXB DMTN	1.43e-04	193	182	6	dd376664906caccc9c2065f8e7a364509e18a5cc
ToppCell	PND01\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FOXO3 FN1 SIK1 MED13L TFCP2L1 MACF1	1.43e-04	193	182	6	c291345c11cfcbceacbdc001a5851f67478a2779
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	ZEB1 CYBRD1 FN1 TSHZ2 NFIA TNXB	1.47e-04	194	182	6	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	10x5'-blood-Lymphocytic_NK-NK_CD16\|blood / Manually curated celltypes from each tissue	TMIGD2 SH2D2A CREM MEX3C LGALS9 FGFBP2	1.47e-04	194	182	6	c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e
ToppCell	T_cells-CD56_dim_CD16+_NK_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	TMIGD2 GOLM1 SH2D2A ADCY7 MEX3C FGFBP2	1.47e-04	194	182	6	335c6c2f3f319d4f19eace62f8826a0f40c130f6
ToppCell	IPF-Endothelial-Lymphatic\|Endothelial / Disease state, Lineage and Cell class	DENND2A KLF12 TSHZ2 TNFRSF11A HOXD3 DMTN	1.52e-04	195	182	6	de88e9d22044b4b3e29676ad02b3e9299cc920ad
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	KLF12 ZEB1 TSHZ2 TNRC6C USP9Y MACF1	1.52e-04	195	182	6	4bdedd924564a260841a9153604026b57487c83d
ToppCell	10x5'-blood-Lymphocytic_NK\|blood / Manually curated celltypes from each tissue	TMIGD2 SH2D2A CREM MEX3C LGALS9 FGFBP2	1.52e-04	195	182	6	c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	DENND2A FN1 COL6A5 PKNOX2 NAV2 TNXB	1.52e-04	195	182	6	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	COL4A6 TRO KIAA1614 KSR1 ZNF469 NAV2	1.52e-04	195	182	6	5562665dd3beb70e2358aa32611a337bef5731c1
Computational	Neighborhood of MYST2	FOXO3 ARID1A POM121C REPIN1 PHC1 MEX3C NCOA5 EIF4ENIF1 SS18L1	2.81e-05	172	99	9	GCM_MYST2
Drug	CGS 22492	REN ADORA2A ADORA2B TCFL5	1.19e-07	7	176	4	CID000130199
Drug	FK453	REN ADORA2A ADORA2B TCFL5	2.36e-07	8	176	4	CID006439091
Drug	N6-cyclohexyladenosine	TNFSF13 REN ADCY7 ADORA2A ADORA2B TCFL5	6.05e-07	40	176	6	CID000002692
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	MED13L ARID1A CREBBP SLC25A22 WDR74 TMPO BICRAL LSM14B TASOR EP300	1.01e-06	173	176	10	2881_DN
Drug	2-H-Ado	ADORA2A ADORA2B TCFL5	1.81e-06	4	176	3	CID000146206
Drug	AC1L1C6L	SP3 ADORA2A ADORA2B SNRNP40 TCFL5	4.43e-06	32	176	5	CID000001763
Drug	CGS 22989	REN ADORA2A ADORA2B	4.49e-06	5	176	3	CID000130198
Drug	soluflazine	ADORA2A ADORA2B TCFL5	8.93e-06	6	176	3	CID000163885
Drug	NSC517192	ADORA2A ADORA2B TCFL5	1.55e-05	7	176	3	CID000004405
Drug	Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A	HJURP MED13L ZNF236 CREM SLC25A22 MTA1 BICRAL KLK5 EP300	1.85e-05	191	176	9	2857_DN
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; PC3; HT_HG-U133A	DENND2A FAT4 MARCHF7 CREM MTA1 PER3 MED25 DLG1 RAPGEFL1	2.01e-05	193	176	9	4623_DN
Drug	5194442; Down 200; 20uM; PC3; HT_HG-U133A	FBXO11 SH2D2A TNFRSF11A PACS1 MED25 CUZD1 TMPO DLG1 LSM14B	2.10e-05	194	176	9	6553_DN
Drug	cox-2 inhibitor I; Down 200; 10uM; MCF7; HG-U133A	FN1 GOLM1 SH2B1 TMPO MACF1 UMPS LSM14B DMTN TNS3	2.47e-05	198	176	9	612_DN
Drug	Chlorphensin carbamate [886-74-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A	DNAH3 ZBTB48 ZNF236 ARID1A ABCA7 SH2B1 MTA1 MZF1 CUZD1	2.47e-05	198	176	9	2279_DN
Drug	Ambroxol hydrochloride [23828-92-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A	MARCHF7 TNFRSF11A BCL9 KSR1 MZF1 PCNX1 KDM6A EP300 GPRIN2	2.47e-05	198	176	9	5319_UP
Drug	PD 115199	ADORA2A ADORA2B TCFL5	2.47e-05	8	176	3	CID000122978
Drug	Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; PC3; HT_HG-U133A	COL4A6 MAML1 USP9Y ZNF236 ARID1A MEGF8 MED25 CUZD1 RAPGEFL1	2.57e-05	199	176	9	3701_DN
Drug	Etodolac [41340-25-4]; Down 200; 14uM; PC3; HT_HG-U133A	ZBTB48 PIEZO1 HMGCR NUP58 MED13L WDR74 MZF1 SMARCC2 KLK5	2.57e-05	199	176	9	7246_DN
Drug	Propantheline bromide [50-34-0]; Up 200; 9uM; MCF7; HT_HG-U133A	KLF12 FN1 TNFRSF11A TSC22D2 CCDC57 TFCP2L1 MTA1 PER3 DMTN	2.67e-05	200	176	9	3352_UP
Drug	DEPX	ADCY7 ADORA2A ADORA2B TCFL5	3.25e-05	24	176	4	CID000001328
Drug	doxofylline	ADORA2A ADORA2B TCFL5	3.69e-05	9	176	3	CID000050942
Drug	diallyl	FN1 ADORA2A ADORA2B TCFL5	3.84e-05	25	176	4	CID000011598
Drug	xanthine	CREBBP ADCY7 ADORA2A ADORA2B DLG1 UMPS TCFL5	3.96e-05	119	176	7	CID000001188
Drug	Nor 3	HMGCR ADORA2A ADORA2B GUSB ATF1	4.17e-05	50	176	5	CID009578441
Drug	DPSPX	REN ADORA2A ADORA2B TCFL5	4.52e-05	26	176	4	CID000001330
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZNF236 ARID1A WDR74 MZF1 TMPO BICRAL TASOR TNS3	4.64e-05	166	176	8	7324_DN
Drug	YT-146	ADORA2A ADORA2B TCFL5	5.24e-05	10	176	3	CID000146207
Drug	DCDPC	ADORA2A ADORA2B TCFL5	5.24e-05	10	176	3	CID000087345
Drug	alpha-hydroxyalprazolam	ZEB1 GUSB DMTN	5.24e-05	10	176	3	CID000162244
Drug	AC1NUW3D	ADORA2A ADORA2B	5.94e-05	2	176	2	CID005462119
Drug	4-cyanobenzenesulfonyl chloride	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000039497
Drug	R-AHPIA	ADORA2A ADORA2B	5.94e-05	2	176	2	CID005487050
Drug	I 371	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000520695
Drug	2-hexynyladenosine-5'-N-ethylcarboxamide	REN ADORA2A	5.94e-05	2	176	2	ctd:C076864
Drug	hexahydroindole	SP3 FN1	5.94e-05	2	176	2	CID000579465
Drug	7a61 Compound	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000133093
Drug	6-thiotheophylline	ADORA2A ADORA2B	5.94e-05	2	176	2	CID003036595
Drug	DITC-APEC	ADORA2A ADORA2B	5.94e-05	2	176	2	CID003037834
Drug	Pol 509	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000126925
Drug	SCH442416	ADORA2A ADORA2B	5.94e-05	2	176	2	CID010668061
Drug	NSC 14304	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000076104
Drug	peramine	HMGCR GUSB	5.94e-05	2	176	2	CID000114748
Drug	1,3,5-triisothiocyanatobenzene	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000058712
Drug	1-ethyltheobromine	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000093219
Drug	theophylline 9-beta-D-riboside	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000165142
Drug	9-ethylpurine	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000225353
Drug	1-Butyltheobromine	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000070835
Drug	1,3-phenylene diisothiocyanate	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000018404
Drug	p-hydroxyphenylisopropyladenosine	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000128639
Drug	Cgs-21197	ADORA2A ADORA2B	5.94e-05	2	176	2	CID003082810
Drug	2-iodoadenosine	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000169662
Drug	DITC-XAC	ADORA2A ADORA2B	5.94e-05	2	176	2	CID003082962
Drug	Cpp-adenosine	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000132348
Drug	1-octyne	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000012370
Drug	6-thiocaffeine	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000025768
Drug	CGS 22706	ADORA2A ADORA2B	5.94e-05	2	176	2	CID000132579
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	MED13L ARID1A CREBBP MEX3C WDR74 TMPO EP300 TNS3	5.97e-05	172	176	8	1072_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ZNF236 ARID1A CREBBP CREM WDR74 MED25 TMPO LSM14B	6.74e-05	175	176	8	3787_DN
Drug	APNEA	ADORA2A ADORA2B TCFL5	7.16e-05	11	176	3	CID000004397
Drug	NBTGR	ADORA2A ADORA2B TCFL5	7.16e-05	11	176	3	CID000096048
Drug	methylenedisalicylic acid	TNFRSF11A ADORA2A ADORA2B MTA1 TCFL5	7.24e-05	56	176	5	CID000479504
Drug	methylxanthine	REN ADCY7 ADORA2A ADORA2B TCFL5	7.24e-05	56	176	5	CID000068374
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	ZNF236 ARID1A CREBBP WDR74 TMPO TASOR EP300 TNS3	7.30e-05	177	176	8	1645_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	MED13L ARID1A CREBBP MEX3C WDR74 MZF1 TMPO EP300	7.30e-05	177	176	8	6434_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	MED13L ARID1A CREBBP MEX3C WDR74 TMPO ATF1 TASOR	7.59e-05	178	176	8	1112_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A	MED13L ARID1A REPIN1 CREBBP WDR74 ADORA2B TMPO ATF1	8.87e-05	182	176	8	1951_DN
Drug	1,3-dipropyl-7-methylxanthine	ADORA2A ADORA2B TCFL5	9.49e-05	12	176	3	CID000161713
Drug	N(6)-endonorbornan-2-yl-9-methyladenine	ADORA2A ADORA2B TCFL5	9.49e-05	12	176	3	CID000126615
Drug	ergovaline	HMGCR KY GUSB	9.49e-05	12	176	3	CID000104843
Drug	Isoconazole [27523-40-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A	COMP ARID1A ABCA7 ADCY7 PKNOX2 ADORA2A DLG1 LSM14B	1.07e-04	187	176	8	7211_UP
Drug	PS-b	COMP TRO ADORA2A ADORA2B	1.19e-04	33	176	4	CID000448408
Drug	AC1L1BJN	ADCY7 ADORA2A ADORA2B	1.23e-04	13	176	3	CID000001467
Drug	1-methylisoguanosine	ADORA2A ADORA2B TCFL5	1.23e-04	13	176	3	CID000126323
Drug	HENECA	ADORA2A ADORA2B TCFL5	1.23e-04	13	176	3	CID000164437
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	COL4A6 KLF12 ZEB1 FN1 MEGF8 MED25 CUZD1 LSM14B	1.33e-04	193	176	8	5919_DN
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; HL60; HG-U133A	SP3 MYO1C MARCHF7 FBXO11 MED13L REPIN1 ATF1 CSTF2T	1.33e-04	193	176	8	1982_DN
Drug	D-CPPene	ADORA2A ADORA2B TCFL5 DMTN	1.34e-04	34	176	4	CID006435801
Drug	Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; HL60; HG-U133A	ZNF410 SP3 MYO1C MARCHF7 MED13L MEX3C ATF1 TASOR	1.43e-04	195	176	8	1981_DN
Drug	Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; HL60; HG-U133A	MYO1C MARCHF7 FBXO11 NUP58 MED13L MACF1 ATF1 EP300	1.43e-04	195	176	8	1431_DN
Drug	radicicol; Down 200; 0.1uM; MCF7; HG-U133A	DNAH3 SH2D2A PKNOX2 ADORA2A MZF1 CUZD1 EP300 MYBL2	1.48e-04	196	176	8	325_DN
Drug	Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A	ZBTB48 CREBBP SH2B1 ADORA2A MZF1 PCNX1 BICRAL CSTF2T	1.48e-04	196	176	8	3844_DN
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ZBTB48 SIK1 CRTC1 WNK1 SH2B1 CSTF2T DMTN GPRIN2	1.53e-04	197	176	8	2307_DN
Drug	CP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A	FAT4 BCL9 SLC25A22 YOD1 MTA1 MED25 VGLL1 DMTN	1.53e-04	197	176	8	4557_DN
Drug	Tomatidine [77-59-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A	FN1 CRTC1 TNFRSF11A CCDC57 ADORA2A KSR1 PER3 DMTN	1.53e-04	197	176	8	2746_UP
Drug	Picrotoxinin [17617-45-7]; Up 200; 13.6uM; HL60; HT_HG-U133A	PADI4 FN1 TNFRSF11A CREM SH2B1 MEGF8 MN1 RAPGEFL1	1.53e-04	197	176	8	2161_UP
Drug	Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A	FN1 TSC22D2 PACS1 MTA1 TMPO PCNX1 LSM14B KDM6A	1.53e-04	197	176	8	5302_UP
Drug	Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; HL60; HG-U133A	MARCHF7 MED13L ARID1A MEX3C TMPO SMARCC2 TASOR EP300	1.53e-04	197	176	8	1371_UP
Drug	Gastrografin	TRO REN TMPO	1.55e-04	14	176	3	CID000008566
Drug	diclofenac sodium; Down 200; 10uM; PC3; HG-U133A	BCL9 PKNOX2 FAM222B TMPO SMARCC2 UMPS CSTF2T GPRIN2	1.59e-04	198	176	8	445_DN
Drug	Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ZBTB48 MARCHF7 FBXO11 CREBBP CREM CUZD1 KLK5 KDM6A	1.59e-04	198	176	8	6041_DN
Drug	Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; MCF7; HT_HG-U133A	PIEZO1 FBXO11 WNK1 PKNOX2 PACS1 MTA1 PROZ PER3	1.59e-04	198	176	8	6765_UP
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A	FN1 MARCHF7 ARID1A CREBBP MACF1 BICRAL TASOR CSTF2T	1.59e-04	198	176	8	5345_DN
Drug	Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; HL60; HG-U133A	SH2D2A ABCA7 ADORA2A MZF1 DLG1 TASOR MAML3 GPRIN2	1.59e-04	198	176	8	1426_UP
Drug	ikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA	ZBTB48 MARCHF7 SLC25A22 MZF1 SMARCC2 KDM6A DMTN RAPGEFL1	1.64e-04	199	176	8	918_DN
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A	KLF12 FAT4 ZEB1 WNK1 ABCA7 MEGF8 MED25 DMTN	1.64e-04	199	176	8	4775_UP
Drug	enprofylline	ADCY7 ADORA2A ADORA2B TCFL5	1.68e-04	36	176	4	CID000001676
Drug	1-allylisoguanosine	ADORA2A ADORA2B	1.77e-04	3	176	2	CID006438736
Drug	1,3,7-tripropylxanthine	ADORA2A ADORA2B	1.77e-04	3	176	2	CID011492842
Drug	I-AB-MECA	ADORA2A ADORA2B	1.77e-04	3	176	2	CID009958472
Drug	Baeta	FN1 REN	1.77e-04	3	176	2	CID000013540
Disease	HMG CoA reductase inhibitor use measurement	HMGCR TSC22D2 ARID1A OIT3 FAM222B NPC1L1 PCNX1 BAG6	1.42e-05	189	169	8	EFO_0009932
Disease	Coffin-Siris syndrome (implicated_via_orthology)	ARID1A SMARCC2 BICRAL	1.51e-05	9	169	3	DOID:1925 (implicated_via_orthology)
Disease	Sezary Syndrome	ZEB1 ARID1A CREBBP KMT2D	1.64e-05	27	169	4	C0036920
Disease	Squamous cell carcinoma of esophagus	FAT4 CREBBP KMT2D KDM6A TNXB EP300	1.84e-05	95	169	6	C0279626
Disease	Adenoid Cystic Carcinoma	FOXO3 ARID1A CREBBP KDM6A MAML3 EP300	2.47e-05	100	169	6	C0010606
Disease	dermoid cyst of ovary (implicated_via_orthology)	FOXO3 FOXO3B	3.26e-05	2	169	2	DOID:5117 (implicated_via_orthology)
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	3.26e-05	2	169	2	180849
Disease	Rubinstein-Taybi syndrome due to CREBBP mutations	CREBBP EP300	3.26e-05	2	169	2	cv:C4551859
Disease	Kabuki syndrome 1	KMT2D KDM6A	3.26e-05	2	169	2	cv:CN030661
Disease	Kabuki syndrome (is_implicated_in)	KMT2D KDM6A	3.26e-05	2	169	2	DOID:0060473 (is_implicated_in)
Disease	Early myoclonic encephalopathy	SIK1 SLC25A22	3.26e-05	2	169	2	C0270855
Disease	Menke-Hennekam syndrome	CREBBP EP300	3.26e-05	2	169	2	cv:C5681632
Disease	Rubinstein-Taybi syndrome (implicated_via_orthology)	CREBBP EP300	3.26e-05	2	169	2	DOID:1933 (implicated_via_orthology)
Disease	Rubinstein-Taybi syndrome	CREBBP EP300	3.26e-05	2	169	2	cv:C0035934
Disease	RUBINSTEIN-TAYBI SYNDROME 1	CREBBP EP300	3.26e-05	2	169	2	C4551859
Disease	Rubinstein-Taybi syndrome (is_implicated_in)	CREBBP EP300	3.26e-05	2	169	2	DOID:1933 (is_implicated_in)
Disease	KABUKI SYNDROME 1	KMT2D KDM6A	3.26e-05	2	169	2	147920
Disease	Rubinstein-Taybi Syndrome	CREBBP EP300	3.26e-05	2	169	2	C0035934
Disease	Carcinoma, Transitional Cell	ARID1A CREBBP KDM6A EP300	8.91e-05	41	169	4	C0007138
Disease	Kabuki syndrome (implicated_via_orthology)	KMT2D KDM6A	9.75e-05	3	169	2	DOID:0060473 (implicated_via_orthology)
Disease	Joint Instability	COMP ZNF469	9.75e-05	3	169	2	C0022410
Disease	Joint laxity	COMP ZNF469	9.75e-05	3	169	2	C0086437
Disease	Early myoclonic encephalopathy	SIK1 SLC25A22	9.75e-05	3	169	2	cv:C0270855
Disease	T-Cell Lymphoma	ARID1A KMT2D EP300	9.78e-05	16	169	3	C0079772
Disease	testosterone measurement	SOX1 SHROOM3 UBQLN2 TNFSF13 TSHZ2 FBXO11 REN TSC22D2 ARID1A MIDEAS REXO1 SH2B1 ARHGEF15 SLC30A6 PKNOX2 PER3 NFIA MACF1 TNS3	1.37e-04	1275	169	19	EFO_0004908
Disease	Kabuki make-up syndrome	KMT2D KDM6A	1.94e-04	4	169	2	C0796004
Disease	non-high density lipoprotein cholesterol measurement	KLF12 FN1 HMGCR ARID1A MIDEAS ARHGEF15 PHC1 OIT3 POM121 NFIA NPC1L1 HYDIN DMTN	2.51e-04	713	169	13	EFO_0005689
Disease	Diffuse Large B-Cell Lymphoma	FBXO11 CREBBP KMT2D EP300	2.82e-04	55	169	4	C0079744
Disease	Polymorphous corneal dystrophy	ZEB1 VSX1	3.22e-04	5	169	2	C0339284
Disease	galectin-9 measurement	LGALS9 KSR1	3.22e-04	5	169	2	EFO_0021863
Disease	pseudohypoaldosteronism (implicated_via_orthology)	WNK1 WNK2	4.82e-04	6	169	2	DOID:4479 (implicated_via_orthology)
Disease	glucagon measurement, glucose tolerance test	MACF1 HERC1	4.82e-04	6	169	2	EFO_0004307, EFO_0008463
Disease	osteoarthritis biomarker measurement	CRTC1 CSMD1	4.82e-04	6	169	2	EFO_0005890
Disease	waist-hip ratio	FOXO3 CYBRD1 FN1 TSHZ2 CRTC1 TSC22D2 WNK1 SH2B1 PHC1 ADORA2B KY MEGF8 TNRC6A DLG1 PCNX1 MN1 MAML3	7.06e-04	1226	169	17	EFO_0004343
Disease	hair colour measurement	PADI4 SHROOM3 PIEZO1 SIK1 ARID1A MYEF2 ZNF469 KMT2D NFIA PCNX1 SIPA1L2	8.79e-04	615	169	11	EFO_0007822
Disease	coronary aneurysm	TSHZ2 NAV2 CSMD1	1.06e-03	35	169	3	EFO_1000881
Disease	severe acute respiratory syndrome, COVID-19	KLF12 POTEF CRTC1 REXO1 KSR1 NFIA FAM222B CSMD1 SIPA1L2	1.15e-03	447	169	9	EFO_0000694, MONDO_0100096
Disease	Intellectual Disability	MED13L PACS1 ALKBH8 NFIA PURA SMARCC2 MACF1 UMPS MN1	1.15e-03	447	169	9	C3714756
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	TSC22D2 POM121C PACS1 TNRC6A DLG1 MACF1 MAML3 HOMEZ	1.24e-03	364	169	8	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	lung non-small cell carcinoma (is_implicated_in)	FBXO11 ARID1A KMT2D KDM6A BAG6	1.26e-03	139	169	5	DOID:3908 (is_implicated_in)
Disease	Bladder Neoplasm	ARID1A CREBBP KMT2D KDM6A EP300	1.30e-03	140	169	5	C0005695
Disease	cardiovascular disease	PLB1 CRTC1 HMGCR TSC22D2 REXO1 MEX3C NPC1L1 PCNX1 SIPA1L2	1.34e-03	457	169	9	EFO_0000319
Disease	Malignant neoplasm of urinary bladder	ARID1A CREBBP KMT2D KDM6A EP300	1.34e-03	141	169	5	C0005684
Disease	neutrophil count, eosinophil count	MYO1C MAML1 MARCHF7 ABCA7 TNS3 RAPGEFL1	1.47e-03	213	169	6	EFO_0004833, EFO_0004842
Disease	acute myeloid leukemia (implicated_via_orthology)	CREBBP MYBL2	2.07e-03	12	169	2	DOID:9119 (implicated_via_orthology)
Disease	body fat percentage	CRTC1 TSC22D2 POM121C PACS1 TNRC6A DLG1 MACF1 MAML3 HOMEZ	2.09e-03	488	169	9	EFO_0007800
Disease	serum gamma-glutamyl transferase measurement	FOXO3 SP3 PLB1 ZEB1 ARID1A POM121C ARHGEF15 POM121 NAV2 CSMD1 LSM14B SIPA1L2 DMTN	2.42e-03	914	169	13	EFO_0004532
Disease	Coffin-Siris syndrome	ARID1A SMARCC2	2.44e-03	13	169	2	C0265338
Disease	body weight	FOXO3 CYBRD1 PARK7 CRTC1 TSC22D2 POM121C SH2B1 MEX3C TFCP2L1 USF3 GUSB TNRC6A ITIH6 MAML3 HOMEZ RAPGEFL1	2.50e-03	1261	169	16	EFO_0004338
Disease	Liver carcinoma	PARK7 HJURP HMGCR ARID1A OIT3 CSPG4 UMPS CSMD1 MYBL2	2.70e-03	507	169	9	C2239176
Disease	fertility measurement	SIK1 NAV2	2.84e-03	14	169	2	EFO_0006923
Disease	Adenocarcinoma Of Esophagus	CRTC1 ARID1A	2.84e-03	14	169	2	C0279628
Disease	response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin	BCL9 CSMD1	2.84e-03	14	169	2	EFO_0005400, GO_0036275, GO_1902518, GO_1902520
Disease	Germ Cell Cancer	PHC1 ATF7IP	3.26e-03	15	169	2	C0740345
Disease	Situs ambiguus	BCL9L SHROOM3	3.26e-03	15	169	2	C0266642
Disease	Embryonal Neoplasm	PHC1 ATF7IP	3.26e-03	15	169	2	C0027654
Disease	Neoplasms, Germ Cell and Embryonal	PHC1 ATF7IP	3.26e-03	15	169	2	C0027658
Disease	Lymphoma, Follicular, Grade 2	CREBBP KMT2D	3.26e-03	15	169	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	CREBBP KMT2D	3.26e-03	15	169	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	CREBBP KMT2D	3.26e-03	15	169	2	C1956130
Disease	myelodysplastic syndrome (implicated_via_orthology)	CREBBP MYBL2	3.26e-03	15	169	2	DOID:0050908 (implicated_via_orthology)
Disease	Lymphoma, Large-Cell, Follicular	CREBBP KMT2D	3.26e-03	15	169	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	CREBBP KMT2D	3.26e-03	15	169	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	CREBBP KMT2D	3.26e-03	15	169	2	C0079758
Disease	Germ cell tumor	PHC1 ATF7IP	3.26e-03	15	169	2	C0205851
Disease	Neoplasms, Embryonal and Mixed	PHC1 ATF7IP	3.26e-03	15	169	2	C0205852
Disease	Cancer, Embryonal	PHC1 ATF7IP	3.26e-03	15	169	2	C0751364
Disease	Cancer, Embryonal and Mixed	PHC1 ATF7IP	3.26e-03	15	169	2	C0751365
Disease	Leukemia, Myelocytic, Acute	CREBBP ADCY7 MN1 EP300 SLX4	3.27e-03	173	169	5	C0023467
Disease	apolipoprotein A 1 measurement, apolipoprotein B measurement	HMGCR ARID1A MIDEAS NPC1L1	3.39e-03	107	169	4	EFO_0004614, EFO_0004615
Disease	neuroimaging measurement	FOXO3 SHROOM3 TSC22D2 POM121C YOD1 ZNF469 NFIA TNRC6A NAV2 MACF1 UMPS WNK2 DMTN AGAP3	3.50e-03	1069	169	14	EFO_0004346
Disease	Early infantile epileptic encephalopathy with suppression bursts	SIK1 SLC25A22	3.71e-03	16	169	2	C0393706
Disease	QT interval	SP3 KLF12 COMP SH2D2A CREBBP SH2B1 NFIA FGFBP2 TASOR	3.79e-03	534	169	9	EFO_0004682
Disease	alcohol dependence measurement	PKNOX2 BPNT2 TNS3	3.89e-03	55	169	3	EFO_0007835
Disease	schizophrenia, intelligence, self reported educational attainment	FOXO3 SEH1L CRTC1 SH2B1 ATF7IP PCNX1 MAML3	3.92e-03	346	169	7	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	Breast Carcinoma	ZEB1 FN1 ARID1A PHGDH KMT2D ALKBH8 PER3 UMPS EP300	3.98e-03	538	169	9	C0678222
Disease	sex interaction measurement, ulcerative colitis	SH2B1 TNXB	4.19e-03	17	169	2	EFO_0000729, EFO_0008343
Disease	Withdrawal Symptoms	REN ADORA2A PER3	4.52e-03	58	169	3	C0087169
Disease	Drug Withdrawal Symptoms	REN ADORA2A PER3	4.52e-03	58	169	3	C0086189
Disease	Substance Withdrawal Syndrome	REN ADORA2A PER3	4.52e-03	58	169	3	C0038587
Disease	Endometrial Neoplasms	ZEB1 ARID1A EP300	4.52e-03	58	169	3	C0014170
Disease	vital capacity	FOXO3 DENND2A SHROOM3 ZNF628 FN1 MYO1C PIEZO1 SIX4 SH2B1 KY NFIA GUSB DLG1 TNXB AGAP3	5.10e-03	1236	169	15	EFO_0004312
Disease	glomerulonephritis (is_marker_for)	FN1 EP300	5.23e-03	19	169	2	DOID:2921 (is_marker_for)
Disease	alcohol use disorder (implicated_via_orthology)	ARID1A CREBBP SMARCC2 KDM6A EP300	5.41e-03	195	169	5	DOID:1574 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
PAVHINQATNGGGSA	AGAP3	281	Q96P47
VERSNTQLGGGTGAP	AGAP3	451	Q96P47
GLGNPSSLGVGQQSA	EP300	436	Q09472
AENGAPGEQGLQGLT	COL4A6	756	Q14031
SVPAISGGNVIQGSG	APLF	201	Q8IW19
NSTILHPNGGTEQGA	CYBRD1	231	Q53TN4
NCGGLVQGPNGTIES	CSMD1	31	Q96PZ7
NGSSLVVPQGGQGTI	CSPG4	1131	Q6UVK1
PVSGTLQGAGLGTNA	BAG6	521	P46379
VSGGSAQESQGNTGL	ADORA2A	366	P29274
KSGNGQAGVQPALGV	ADORA2B	316	P29275
ATQSLVVANGGLGNG	ALKBH8	41	Q96BT7
LTLAALGASGQGQSP	COMP	11	P49747
LGASGQGQSPLGSDL	COMP	16	P49747
NSGLGFSIAGGTDNP	DLG1	231	Q12959
IIGGNSQFTINPSTG	FAT4	2401	Q6V0I7
IGNVSASSPVQQGLG	CREBBP	86	Q92793
ASSPVQQGLGGQAQG	CREBBP	91	Q92793
SGIQNTIGSVGTGQQ	CREBBP	451	Q92793
SPAQTGQLQSTLGGR	CCDC142	696	Q17RM4
GVLAQNGSASAPGTV	ARHGEF15	136	O94989
GQGLGNLTKPNGTTS	ADCY7	771	P51828
NGSQGSRVGTPQLLA	ABCA7	1066	Q8IZY2
SEPQGSGRQGNSLGA	HJURP	686	Q8NCD3
AGQVGFLNPNGSSQG	NFIA	411	Q12857
QPGTGQHDLVQSGTG	QRICH2	476	Q9H0J4
QSGTGQGVLVQPGVD	QRICH2	486	Q9H0J4
GLPENLTNGASAGNG	POTEB2	391	H3BUK9
GVSQQAAGTKAGPAG	YOD1	21	Q5VVQ6
QQSPGLAALQSGGGG	ARID1A	176	O14497
PQTGGISGLDSFGNL	PADI4	396	Q9UM07
QLGSPQVRAGSAGQT	MAML1	311	Q92585
GFPENLTNGATAGNG	POTEF	551	A5A3E0
GSVVAQGNGAPASNR	ADIPOR1	6	Q96A54
VGGQNPSTGGISADR	MED13L	1611	Q71F56
VNSLLVQGGVGSLPG	TMPO	381	P42166
SLNSSLGGAGIGVNN	MAML3	21	Q96JK9
LGGAGIGVNNTPNST	MAML3	26	Q96JK9
QQGAPSVQGPSGTQS	HSFX4	226	A0A1B0GTS1
SGQEPASRGQGQSQG	MAPK8IP1	131	Q9UQF2
EIGTVGGGTNLLPQQ	HMGCR	801	P04035
NPSSLLQRGGGFQGV	KY	36	Q8NBH2
PGKGTTGTQLNGRQA	LSM14B	176	Q9BX40
PFSGTIQGGLQDGLQ	LGALS9	16	O00182
QLQQPSTSASEGGGL	HERC1	1471	Q15751
AAGSGIQNQNGHPTL	KDM6A	671	O15550
TSQLQLQRSPGGTFG	KIAA1614	1131	Q5VZ46
SNVTQGSIGNPGQGS	PCNX1	2071	Q96RV3
TNGRSIDTGGGAPQI	PER3	601	P56645
GSSQLGRAGNSAQGP	KSR1	211	Q8IVT5
SAGLQGQTLTGGPIR	OIT3	526	Q8WWZ8
VLPGGNLGAQNLSES	PARK7	71	Q99497
GNQPPSILGQGGSAQ	NCOA5	481	Q9HCD5
RAGTGGGPVASQNSL	FAM222B	496	Q8WU58
AQGQLSAQGGAQPSV	SLC25A22	146	Q9H936
GTLGQAPRQKQGSTG	FGFBP2	16	Q9BYJ0
QGQLNGSAGPGHSEL	MEGF8	806	Q7Z7M0
QPQGTVGASGATGQP	MED25	591	Q71SY5
VGASGATGQPQPQGT	MED25	596	Q71SY5
TGNGGGVINLNAFDP	FAHD2A	46	Q96GK7
TVPSGSNQDLGAGAG	KLK5	41	Q9Y337
PSGAGCQVGINQNGT	EDC3	86	Q96F86
SNGGGFASANLQGSP	HOXD3	341	P31249
QQGAPSVQGPSGTQS	HSFX3	226	A0A1B0GWH4
TFGNQTTIIPAGGAG	BPNT2	256	Q9NX62
SVGSSGGQLLTNLPG	MACF1	3761	Q9UPN3
GGSGQRGSGVAQSPQ	PACS1	16	Q6VY07
GLGQNALGTTGQSTP	POM121C	1126	A8CG34
TPFAGGLGQNALGTT	POM121B	726	A6NF01
GLGQNALGTTGQSTP	POM121B	731	A6NF01
GQAVGSGIQPLNEGV	NPC1L1	226	Q9UHC9
GFPENLTNGATAGNG	POTEE	551	Q6S8J3
AGGSSLQTQRGLPGS	PRICKLE4	251	Q2TBC4
TPFAGGLGQNALGTT	POM121	1141	Q96HA1
GLGQNALGTTGQSTP	POM121	1146	Q96HA1
VSATGAANGLNNGAG	COG6	11	Q9Y2V7
AGGLSGGTQALLQPQ	FOXO3B	201	A0A2Z4LIS9
AGVQGGSELPLGSQL	C5orf47	61	Q569G3
GVTPSGNIGANGVAI	IDH3A	271	P50213
GFGSIPSGGQQVINV	HYDIN	3271	Q4G0P3
SGQQAPSNVSGGLLV	BICRAL	241	Q6AI39
PQQLVAATAASGGGA	DACT3	576	Q96B18
GTRTQTISLGQGQGP	DNAH3	3546	Q8TD57
LPENLGGGSGSEVSQ	DENND2A	201	Q9ULE3
TGNGGGVINLNAFDP	FAHD2B	46	Q6P2I3
YGGSLPNVNQIGSGT	CRTC1	61	Q6UUV9
PTIRGNSIFNGNQGG	FBXO11	536	Q86XK2
TGNGIQLPGTSGQQP	FN1	2121	P02751
TGLGTQSQPSDGAPQ	GAS2L3	531	Q86XJ1
TGAQSGGPQQNPGVL	BCL9	381	O00512
ANGTGTQGQLKVPGV	GUSB	271	P08236
SNQGAPRQGGSIGSG	CCDC188	111	H7C350
QGRSGQKGVQGSPSS	COL6A5	1536	A8TX70
GTLGAEGLQGPQGSQ	COL6A5	1576	A8TX70
PGNGQRSLVGSEGLS	BCL9L	386	Q86UU0
QAGQAGGSVQAGPVS	CCDC57	641	Q2TAC2
VVNNGLTLGSTGPQL	ATF7IP	1106	Q6VMQ6
SAQGGRNTGISGILP	MARCHF7	466	Q9H992
DGAGTQPGQEATGNL	MIDEAS	361	Q6PJG2
NGSGLSPSARGLIGQ	ITIH6	1231	Q6UXX5
GPLVASASGVGGQQF	KLF12	146	Q9Y4X4
GGIQGASKQGGSQPS	CSTF2T	546	Q9H0L4
EQAGRGPNQSHGIGT	HOMEZ	231	Q8IX15
DGPSTNSGLIGQVCG	CUZD1	216	Q86UP6
GGAGELGQTPQVQAA	GOLM1	291	Q8NBJ4
VHRAQLQPGGTSGQG	GPRIN2	151	O60269
AIAQGGTIQISNPGS	CREM	171	Q03060
GTIQISNPGSDGVQG	CREM	176	Q03060
SNPGSDGVQGLQALT	CREM	181	Q03060
SETGSPGLQNGEGQR	DMTN	311	Q08495
GNGSPVNGSSQQGTS	SEH1L	321	Q96EE3
AAGVLQQQGGAPGTN	PKNOX2	381	Q96KN3
QQQGGAPGTNPDGSI	PKNOX2	386	Q96KN3
SNPASAGFGTGGQLL	NUP58	571	Q9BVL2
QFGGSLGGLGQLQSP	MN1	701	Q10571
APGVSPGQQQASGAA	MN1	971	Q10571
PGQQQASGAAVGGSS	MN1	976	Q10571
SPGIFASSQPGQGNI	MS4A12	56	Q9NXJ0
STSNGKPGAVNGAVG	MTA3	351	Q9BTC8
AGGLSGGTQALLQPQ	FOXO3	116	O43524
GSQSSNGPEPGGQQL	REXO1	756	Q8N1G1
PPVLGGNSNSNSSGG	SH2B1	191	Q9NRF2
HLQGLPGANGSSVSQ	TNRC6C	221	Q9HCJ0
PQGSALGLSTQGQAF	SUPT20HL1	661	Q3ZLR7
PGGQNTGGSQLHSEN	SH2D2A	331	Q9NP31
LPVGTGQNASSVGAQ	TSC22D2	411	O75157
QAGLTQQPGGTVVAG	SLC25A34	96	Q6PIV7
GGQPISASQLNIGGV	MYEF2	341	Q9P2K5
GLQSAQPTEGQGSLL	MYBL2	211	P10244
GLPENLTNGASAGNG	POTEB	391	A0A0A6YYL3
QSLGGQIVLGGSDPQ	REN	236	P00797
SSQLGRPGISTQQGN	MARCOL	126	A0A1B0GUY1
GKPGSSSQQGNLGTS	MARCOL	211	A0A1B0GUY1
ASQTQQIPGGSLGSV	MEX3C	151	Q5U5Q3
TQQGNLDSPSGSGVL	NAV2	1356	Q8IVL1
LGAGSGPGAGQQQAT	SNRNP40	26	Q96DI7
LNASNSNETGGGGPA	SIPA1L2	51	Q9P2F8
GNSFIQGPSGVILNG	SIX4	366	Q9UIU6
LTQPPNGNQTSSGTG	SIMC1	626	Q8NDZ2
QSATPVLQAQGGLGG	SIK1B	546	A0A0B4J2F2
QSATPVLQAQGGLGG	SIK1	546	P57059
QPCGQQLSGGASDSG	SHROOM3	861	Q8TF72
GFPENLTNGATAGNG	POTEI	551	P0CG38
FLTGVLGSQPVGGQA	PROZ	366	P22891
NVKAGVVNGTGAPGQ	MTA1	371	Q13330
LTAGNGAGSTPGNVL	PLB1	401	Q6P1J6
QGAGAGVNGTVPLTH	SOX1	376	O00570
QANGSVSPDSVGGGL	TNS3	726	Q68CZ2
ATGRQGSSAEQPLGG	TNS3	756	Q68CZ2
NGSPNSFGLGEGNAS	TFCP2L1	276	Q9NZI6
GLPGSGNTQPSGNTA	NPAP1	726	Q9NZP6
AGSTAGPQQQQPAGA	SMARCC2	1016	Q8TAQ2
QGTSVAQSGAQAPGR	REPIN1	41	Q9BWE0
EGGSPVSGQLLAGVQ	SLX4	881	Q8IY92
QPGPQGSTLGLSTQG	SUPT20HL2	686	P0C7V6
LPELESSQQNGGGGG	TASOR	31	Q9UK61
AGLEQAILSPGQNSG	EIF4ENIF1	366	Q9NRA8
GALQLASPGTDGVQG	ATF1	116	P18846
QGAELLNSGTLGPQS	CFAP20DC	276	Q6ZVT6
SSLLQGQIGNGPSHV	SS18L1	116	O75177
PGAGAQGGSNSTALE	VSX1	341	Q9NZR4
PKTSVGQAAGGQSGL	ZBTB48	116	P10074
GQSGLGPPASQNVNS	ZBTB48	126	P10074
TPGGNSVIVGNTHGQ	WDR74	236	Q6RFH5
ITNGSLSLGVCGPQG	TMIGD2	71	Q96BF3
QGSQSPTGHEGGTIQ	TRO	151	Q12816
VQGVAIGGSSFPGQT	SP3	236	Q02447
GGESLNLPNTNSILG	ZNF410	406	Q86VK4
GGQNQEILLPGGITS	TNXB	3971	P22105
TPGVQLEAGGDNLGQ	UMPS	416	P11172
PQQELTGPGSGASSQ	SLC4A5	66	Q9BY07
GATNQSLNLSQAGGG	PHC1	256	P78364
QTGLPTGLTENQSGG	PHC1	766	P78364
PGGNSQGTAVQGITF	USF3	156	Q68DE3
TQASGLGPQAVGGRQ	PYCARD-AS1	141	I3L0S3
HGSPVGGNDSQGQVL	USP9Y	6	O00507
SGSVAQLQGGNDTGT	TSHZ2	36	Q9NRE2
TGGGSQPQPASGQLQ	ZNF469	3716	Q96JG9
QNGVFTGGGPLQATS	ZEB1	371	P37275
PGIGATQGLRTGFTN	SLC30A6	431	Q6NXT4
STPGLSQGGETCQQG	ZNF835	511	Q9Y2P0
SGQGGAGSPQVILVS	ZNF236	1606	Q9UL36
GLVQGTTPVLQGLNG	PHGDH	436	O43175
QEQAGQLPTGGGPSQ	PIEZO1	1471	Q92508
ISTNSNPFGLGSLGG	UBQLN2	136	Q9UHD9
GGQVQVSQPGGSLAQ	WNK1	1011	Q9H4A3
GTVGGQASHPQTLGA	WNK2	1746	Q9Y3S1
QTSQLAGRTVAGGPG	RAPGEFL1	11	Q9UHV5
NLGNGTSLPVLEGQS	SIGLEC10	361	Q96LC7
LGEQAQSGPQGGRSQ	TCFL5	386	Q9UL49
PGSLSNVSDNAGVQG	UHRF1BP1	1146	Q6BDS2
ARENGNPGQIAGSTG	VGLL1	186	Q99990
RGPGLGSTQGQTIAL	PURA	176	Q00577
GSTQGQTIALPAQGL	PURA	181	Q00577
GPNGQANGDTVNATL	TNRC6A	536	Q8NDV7
EVSRLQGTGGPSQNG	TNFSF13	61	O75888
QLTQGASGDSQLGQP	ZNF805	111	Q5CZA5
QGQATVFPGLATAGG	TEX13B	161	Q9BXU2
ALTGVLSGNGGTNVN	YTHDF1	211	Q9BYJ9
SGGAGSDSNSPGNVQ	YTHDF1	341	Q9BYJ9
GGQSPASGNVTGNSN	TNFRSF11A	516	Q9Y6Q6
QLQPVAGQLSNSSGG	ZNF628	866	Q5EBL2
QQQQHSGGAGSLAGP	KMT2D	3681	O14686
ININQGSITFAGGPG	MYO1C	1016	O00159
EAGGSGDVPSTGQNN	SLC8A3	31	P57103
AGLSGQIQSPSREGG	MZF1	286	P28698